Federal Register of Legislation - Australian Government

Primary content

Determinations/Health as amended, taking into account amendments up to National Health (Continued Dispensing – Emergency Measures) Amendment Determination 2020 (No. 9) (PB 105 of 2020)
Administered by: Health
Registered 17 Nov 2020
Start Date 01 Nov 2020

Commonwealth Coat of Arms of Australia

National Health (Continued Dispensing – Emergency Measures) Determination 2020

made under subsection 89A(3) of the

National Health Act 1953

Compilation No. 9

Compilation date:                              1 November 2020

Includes amendments up to:            PB 105 of 2020

Registered:                                         17 November 2020

About this compilation

This compilation

This is a compilation of the National Health (Continued Dispensing – Emergency Measures) Determination 2020 that shows the text of the law as amended and in force on 1 November 2020 (the compilation date).

The notes at the end of this compilation (the endnotes) include information about amending laws and the amendment history of provisions of the compiled law.

Uncommenced amendments

The effect of uncommenced amendments is not shown in the text of the compiled law. Any uncommenced amendments affecting the law are accessible on the Legislation Register (www.legislation.gov.au). The details of amendments made up to, but not commenced at, the compilation date are underlined in the endnotes. For more information on any uncommenced amendments, see the series page on the Legislation Register for the compiled law.

Application, saving and transitional provisions for provisions and amendments

If the operation of a provision or amendment of the compiled law is affected by an application, saving or transitional provision that is not included in this compilation, details are included in the endnotes.

Editorial changes

For more information about any editorial changes made in this compilation, see the endnotes.

Modifications

If the compiled law is modified by another law, the compiled law operates as modified but the modification does not amend the text of the law. Accordingly, this compilation does not show the text of the compiled law as modified. For more information on any modifications, see the series page on the Legislation Register for the compiled law.

Self-repealing provisions

If a provision of the compiled law has been repealed in accordance with a provision of the law, details are included in the endnotes.

  

  

  


Contents

Part 1—Preliminary                                                                                                                                        1

1.01....... Name............................................................................................................................. 1

1.03....... Authority....................................................................................................................... 1

1.04....... Definitions..................................................................................................................... 1

1.05....... Purpose......................................................................................................................... 1

1.06....... Operation of this instrument.......................................................................................... 2

Part 2—Conditions                                                                                                                                          3

2.01....... General.......................................................................................................................... 3

2.02....... Not practicable to obtain prescription............................................................................ 3

2.03....... Previous supply of pharmaceutical benefit.................................................................... 3

2.04....... Stability of therapy........................................................................................................ 3

2.05....... Prior clinical review by PBS prescriber......................................................................... 3

2.06....... Prescription for last supply of pharmaceutical benefit................................................... 4

2.07....... Continued dispensing in previous 12 months................................................................ 4

2.08....... Declaration by person supplied with pharmaceutical benefit......................................... 4

2.09....... Maximum quantity of supply........................................................................................ 4

2.10....... Preparing and recording information............................................................................. 4

Part 3—Pharmaceutical benefits                                                                                                            6

3.01....... Pharmaceutical benefits................................................................................................. 6

Schedule 1 – Pharmaceutical Benefits                                                                                7

Endnotes                                                                                                                                                               56

Endnote 1—About the endnotes                                                                                                      56

Endnote 2—Abbreviation key                                                                                                          56

Endnote 3—Legislation history                                                                                                       56

Endnote 4—Amendment history                                                                                                     56

 


Part 1Preliminary

  

1.01  Name

                   This instrument is the National Health (Continued Dispensing – Emergency Measures) Determination 2020.

1.03  Authority

                   This instrument is made under subsection 89A(3) of the National Health Act 1953.

1.04  Definitions

             (1)  In this determination:

Act means the National Health Act 1953.

prescriber bag provisions has the meaning given by subsection 84(1) of the Act.

PSA Guidelines means the document titled Guidelines for the Continued Dispensing of eligible prescribed medicines by pharmacists, issued by the Pharmaceutical Society of Australia.

requested supply: see subsection 2.01(1).

             (2)  In this determination, the following terms have the same meaning as in Part VII of the Act:

                        ·  approved pharmacist

                        ·  listed brand

                        ·  PBS prescriber

                        ·  pharmaceutical benefit

                        ·  pharmaceutical item.

                        ·  Schedule equivalent

1.05  Purpose

                   This determination specifies the pharmaceutical benefits that may be supplied, and the conditions that must be satisfied when those pharmaceutical benefits are supplied, by an approved pharmacist without a current prescription, but on the basis of a previous prescription from a PBS prescriber.

1.06  Operation of this instrument

                   This instrument does not apply to the following:

(a)  the supply of pharmaceutical benefits in accordance with special arrangements under section 100 of Act; and

(b)  the supply of pharmaceutical benefits under the prescriber bag provisions under Part VII of the Act.

Part 2Conditions

  

2.01  General

             (1)  For paragraph 89A(3)(b) of the Act, this Part sets out the conditions that must be satisfied when making a supply (the requested supply) of a pharmaceutical benefit to a person under subsection 89A(1) of the Act.

             (2)  An approved pharmacist must consider the PSA Guidelines when:

                     (a)  satisfying the conditions set out in this Part; or

                     (b)  deciding whether those conditions are satisfied.

             (3)  In this Part:

                     (a)  a reference to the person is a reference to the person who requested the supply of a pharmaceutical benefit under subsection 89A(1) of the Act; and

                     (b)  a reference to the PBS prescriber is a reference to the PBS prescriber who most recently prescribed the supply of the pharmaceutical benefit to the person.

                     (c)  a reference to “the pharmaceutical benefit” in sections 2.03, 2.05, 2.06 and 2.07 includes a pharmaceutical benefit that is Schedule equivalent.

2.02  Not practicable to obtain prescription

                   A condition is that the approved pharmacist is satisfied that it is not practicable for the person to obtain a prescription for the pharmaceutical benefit from a PBS prescriber before the person needs the supply of the pharmaceutical benefit.

2.03  Previous supply of pharmaceutical benefit

                   A condition is that the approved pharmacist is satisfied that:

                     (a)  the person has previously been supplied the pharmaceutical benefit on the basis of a prescription from a PBS prescriber; and

                     (b)  the PBS prescriber prescribed the supply of the pharmaceutical benefit for the person in at least one of the circumstances determined for that pharmaceutical benefit under paragraph 85(7)(b) of the Act.

Note:          The circumstances determined under paragraph 85(7)(b) of the Act relate to pharmaceutical benefits that are relevant pharmaceutical benefits under section 88A of the Act.

2.04  Stability of therapy

                   A condition is that the approved pharmacist is satisfied that the person’s therapy is stable.

2.05  Prior clinical review by PBS prescriber

                   A condition is that the approved pharmacist is satisfied that:

                     (a)  the person has been taking the pharmaceutical benefit regularly for an uninterrupted period; and

                     (b)  since the start of that period, the PBS prescriber has assessed the person’s condition and decided that there is a need for ongoing treatment with the pharmaceutical benefit.

Note:          See paragraph 2.01(3)(b) for references to the PBS prescriber.

2.06  Prescription for last supply of pharmaceutical benefit

                   A condition is that the approved pharmacist is satisfied that the person had a valid prescription under Part VII of the Act for the last supply of the pharmaceutical benefit to the person before the requested supply.

2.07  Continued dispensing in previous 12 months

                   A condition is that the approved pharmacist is satisfied that the person was not supplied with the pharmaceutical benefit under subsection 89A(1) of the Act in the 12 months before the requested supply.

2.08  Declaration by person supplied with pharmaceutical benefit

                   A condition is that the person, or an agent of the person (other than the approved pharmacist), signs a declaration acknowledging that the person is being supplied with the pharmaceutical benefit without the presentation of a valid prescription under Part VII of the Act.

2.09  Maximum quantity of supply

                   A condition is that the approved pharmacist supplies the quantity or number of units of the pharmaceutical item in the pharmaceutical benefit determined under paragraph 85A(2)(a) of the Act that is the same quantity or number of units of the pharmaceutical item that was previously supplied under the prescription referred to in section 2.06.

2.10  Preparing and recording information

             (1)  A condition is that, when the pharmaceutical benefit is supplied, the approved pharmacist:

                     (a)  records the information that the pharmacist used to support his or her decision to supply the pharmaceutical benefit; and

                     (b)  prepares information about the supply that the pharmacist will send to the PBS prescriber.

Note:          See the PSA Guidelines for guidance about when the information should be sent to the PBS prescriber.

             (2)  The information that must be recorded and prepared includes the following:

                     (a)  a statement that the pharmaceutical benefit supplied is a pharmaceutical benefit determined under paragraph 89A(3)(a) of the Act;

                     (b)  a statement that the conditions mentioned in sections 2.02 to 2.05 are satisfied;

                     (c)  a statement that the approved pharmacist is satisfied that the pharmaceutical benefit needs to be supplied to the person to facilitate continuity of treatment.

Part 3Pharmaceutical benefits

  

3.01  Pharmaceutical benefits

             (1)  For subsection 89A(3)(a) of the Act, an approved pharmacist may supply without a prescription a pharmaceutical benefit, being any listed brand of a pharmaceutical item mentioned in Schedule 1.

             (2)  For subsection (1), the pharmaceutical item is the listed drug mentioned in Schedule 1:

                     (a)  in the form mentioned in Schedule 1 for the listed drug; and

                     (b)  with the manner of administration mentioned in Schedule 1 for the form of the listed drug.


 

Schedule 1 – Pharmaceutical Benefits

(section 3.01)

  

 

Listed Drug

Form

Manner of Administration

Abatacept

Injection 125 mg in 1 mL single dose autoinjector

Injection

 

Injection 125 mg in 1 mL single dose pre‑filled syringe

Injection

Abemaciclib

Tablet 100 mg

Oral

 

Tablet 150 mg

Oral

 

Tablet 50 mg

Oral

Abiraterone

Tablet containing abiraterone acetate 250 mg

Oral

 

Tablet containing abiraterone acetate 500 mg

Oral

Acalabrutinib

Capsule 100 mg

Oral

Acamprosate

Tablet (enteric coated) containing acamprosate calcium 333 mg

Oral

Acarbose

Tablet 100 mg

Oral

 

Tablet 50 mg

Oral

Acetazolamide

Tablet 250 mg

Oral

Aciclovir

Eye ointment 30 mg per g, 4.5 g (Acivision)

Application to the eye

 

Tablet 200 mg

Oral

 

Tablet 800 mg

Oral

Acitretin

Capsule 10 mg

Oral

 

Capsule 25 mg

Oral

Aclidinium

Powder for oral inhalation in breath actuated device 322 micrograms (as bromide) per dose, 60 doses

Inhalation by mouth

Aclidinium with formoterol

Powder for oral inhalation in breath actuated device containing aclidinium 340 micrograms (as bromide) with formoterol fumarate dihydrate 12 micrograms per dose, 60 doses

Inhalation by mouth

Adalimumab

Injection 20 mg in 0.4 mL pre‑filled syringe

Injection

 

Injection 40 mg in 0.8 mL pre‑filled pen

Injection

 

Injection 40 mg in 0.8 mL pre‑filled pen, 4

Injection

 

Injection 40 mg in 0.8 mL pre‑filled pen, 6

Injection

 

Injection 40 mg in 0.8 mL pre‑filled syringe

Injection

 

Injection 40 mg in 0.8 mL pre‑filled syringe, 6

Injection

Adapalene with benzoyl peroxide

Gel 1 mg‑25 mg per g, 30 g

Application

Adrenaline (epinephrine)

I.M. injection 150 micrograms in 0.3 mL single dose syringe auto‑injector

Injection

 

I.M. injection 300 micrograms in 0.3 mL single dose syringe auto‑injector

Injection

 

Injection 1 mg (as acid tartrate) in 1 mL (1 in 1,000)

Injection

Afatinib

Tablet 20 mg

Oral

 

Tablet 30 mg

Oral

 

Tablet 40 mg

Oral

 

Tablet 50 mg

Oral

Aflibercept

Solution for intravitreal injection 3.6 mg in 90 microlitres (40 mg per mL) pre-filled syringe

Injection

 

Solution for intravitreal injection 4 mg in 100 microlitres (40 mg per mL)

Injection

Albendazole

Tablet 200 mg

Oral

 

Tablet 400 mg

Oral

Alectinib

Capsule 150 mg

Oral

Alendronic acid

Tablet 70 mg (as alendronate sodium)

Oral

Alendronic acid with colecalciferol

Tablet 70 mg (as alendronate sodium) with 140 micrograms colecalciferol

Oral

 

Tablet 70 mg (as alendronate sodium) with 70 micrograms colecalciferol

Oral

Alendronic acid with colecalciferol and calcium

Pack containing 4 tablets containing alendronic acid 70 mg (as alendronate sodium) with 140 micrograms colecalciferol and 48 tablets calcium 500 mg (as carbonate)

Oral

Allopurinol

Tablet 100 mg

Oral

 

Tablet 300 mg

Oral

Alogliptin

Tablet 12.5 mg (as benzoate)

Oral

 

Tablet 25 mg (as benzoate)

Oral

 

Tablet 6.25 mg (as benzoate)

Oral

Alogliptin with metformin

Tablet containing 12.5 mg alogliptin (as benzoate) with 1 g metformin hydrochloride

Oral

 

Tablet containing 12.5 mg alogliptin (as benzoate) with 500 mg metformin hydrochloride

Oral

 

Tablet containing 12.5 mg alogliptin (as benzoate) with 850 mg metformin hydrochloride

Oral

Alprazolam

Tablet 1 mg

Oral

 

Tablet 250 micrograms

Oral

 

Tablet 500 micrograms

Oral

Amantadine

Capsule containing amantadine hydrochloride 100 mg

Oral

Amino acid formula supplemented with prebiotics, probiotics and long chain polyunsaturated fatty acids

Oral powder 400 g (Neocate Syneo)

Oral

Amino acid formula with carbohydrate, vitamins, minerals and trace elements without phenylalanine

Sachets containing oral powder 20 g, 30 (PKU Go)

Oral

Amino acid formula with carbohydrate without phenylalanine

Tablets containing 0.92 g protein, 462 (PKU Easy Tablet)

Oral

Amino acid formula with fat, carbohydrate, vitamins, minerals and long chain polyunsaturated fatty acids without phenylalanine and supplemented with docosahexaenoic acid

Oral liquid 500 mL, 20 (PKU Baby)

Oral

Amino acid formula with fat, carbohydrate, vitamins, minerals and trace elements without phenylalanine

Bottles containing oral powder 34 g, 30 (PKU Easy Shake & Go)

Oral

Amino acid formula with fat, carbohydrate, vitamins, minerals and trace elements without phenylalanine and tyrosine

Bottles containing oral powder 34 g, 30 (TYR Easy Shake & Go)

Oral

Amino acid formula with fat, carbohydrate, vitamins, minerals and trace elements without phenylalanine and tyrosine, and supplemented with docosahexanoic acid

Oral liquid 125 mL, 36 (TYR Anamix junior LQ)

Oral

Amino acid formula with fat, carbohydrate, vitamins, minerals, and trace elements, without methionine and supplemented with docosahexanoic acid

Oral liquid 125 mL, 36 (HCU Anamix junior LQ)

Oral

Amino acid formula with fat, carbohydrate, vitamins, minerals, trace elements and medium chain triglycerides

Oral powder 400 g (Alfamino Junior)

Oral

 

Oral powder 400 g (Neocate Junior)

Oral

Amino acid formula with fat, carbohydrate without methionine

Tablets containing 0.91 g protein, 462 (HCU Easy Tablet)

Oral

Amino acid formula with fat, carbohydrate without phenylalanine

Tablets (modified release), 70.8 g protein per 100 g, 110 g, 4 (PKU Easy Microtabs)

Oral

Amino acid formula with fat, carbohydrate without phenylalanine and tyrosine

Tablets containing 0.91 g protein, 462 (TYR Easy Tablet)

Oral

Amino acid formula with fat, carbohydrate without valine, leucine and isoleucine

Tablets containing 0.91 g protein, 462 (MSUD Easy Tablet)

Oral

Amino acid formula with vitamins and minerals without lysine and low in tryptophan

Oral powder 400 g (GA1 Anamix infant)

Oral

 

Oral powder 500 g (XLYS, LOW TRY Maxamum)

Oral

 

Sachets containing oral powder 18 g, 30 (GA1 Anamix Junior)

Oral

 

Sachets containing oral powder 24 g, 30 (GA gel)

Oral

 

Sachets containing oral powder 25 g, 30 (GA express 15)

Oral

Amino acid formula with vitamins and minerals without methionine

Oral liquid 125 mL, 30 (HCU Lophlex LQ 20)

Oral

 

Oral liquid 130 mL, 30 (HCU cooler 15)

Oral

 

Oral liquid 174 mL, 30 (HCU cooler 20)

Oral

 

Oral liquid 87 mL, 30 (HCU cooler 10)

Oral

 

Oral powder 400 g (HCU Anamix infant)

Oral

 

Oral powder 500 g (XMET Maxamum)

Oral

 

Sachets containing oral powder 24 g, 30 (HCU gel)

Oral

 

Sachets containing oral powder 25 g, 30 (HCU express 15)

Oral

 

Sachets containing oral powder 36 g, 30 (HCU Anamix Junior)

Oral

Amino acid formula with vitamins and minerals without methionine, threonine and valine and low in isoleucine

Oral powder 400 g (MMA/PA Anamix infant)

Oral

 

Oral powder 500 g (XMTVI Maxamum)

Oral

 

Sachets containing oral powder 18 g, 30 (MMA/PA Anamix Junior)

Oral

 

Sachets containing oral powder 24 g, 30 (MMA/PA gel)

Oral

 

Sachets containing oral powder 25 g, 30 (MMA/PA express 15)

Oral

Amino acid formula with vitamins and minerals without phenylalanine

Oral gel 85 g, 30 (PKU squeezie)

Oral

 

Oral liquid 125 mL, 30 (PKU Lophlex LQ 20)

Oral

 

Oral liquid 125 mL, 36 (PKU Anamix Junior LQ)

Oral

 

Oral liquid 130 mL, 30 (PKU Air 15)

Oral

 

Oral liquid 130 mL, 30 (PKU Cooler 15)

Oral

 

Oral liquid 174 mL, 30 (PKU Air 20)

Oral

 

Oral liquid 174 mL, 30 (PKU Cooler 20)

Oral

 

Oral liquid 250 mL (Easiphen)

Oral

 

Oral liquid 62.5 mL, 60 (PKU Lophlex LQ 10)

Oral

 

Oral liquid 87 mL, 30 (PKU Cooler 10)

Oral

 

Oral powder 500 g (XP Maxamum)

Oral

 

Oral semi‑solid 109 g, 36 (PKU Lophlex Sensation 20)

Oral

 

Sachets containing oral powder 24 g, 30 (PKU gel)

Oral

 

Sachets containing oral powder 25 g, 30 (PKU express 15)

Oral

 

Sachets containing oral powder 27.8 g, 30 (PKU Lophlex)

Oral

 

Sachets containing oral powder 28 g, 30 (PKU Lophlex)

Oral

 

Sachets containing oral powder 34 g, 30 (PKU express 20)

Oral

 

Sachets containing oral powder 36 g, 30 (PKU Anamix Junior)

Oral

Amino acid formula with vitamins and minerals without phenylalanine and tyrosine

Oral liquid 125 mL, 30 (TYR Lophlex LQ 20)

Oral

 

Oral liquid 130 mL, 30 (TYR cooler 15)

Oral

 

Oral liquid 174 mL, 30 (TYR cooler 20)

Oral

 

Oral liquid 87 mL, 30 (TYR cooler 10)

Oral

 

Oral powder 400 g (TYR Anamix infant)

Oral

 

Oral powder 500 g (XPhen, Tyr Maxamum)

Oral

 

Sachets containing oral powder 24 g, 30 (TYR gel)

Oral

 

Sachets containing oral powder 25 g, 30 (TYR express 15)

Oral

 

Sachets containing oral powder 34 g, 30 (TYR express 20)

Oral

 

Sachets containing oral powder 36 g, 30 (TYR Anamix Junior)

Oral

Amino acid formula with vitamins and minerals without valine, leucine and isoleucine

Oral liquid 125 mL, 30 (MSUD Lophlex LQ 20)

Oral

 

Oral liquid 130 mL, 30 (MSUD cooler 15)

Oral

 

Oral liquid 174 mL, 30 (MSUD cooler 20)

Oral

 

Oral liquid 87 mL, 30 (MSUD cooler 10)

Oral

 

Oral powder 400 g (MSUD Anamix infant)

Oral

 

Oral powder 500 g (MSUD AID III)

Oral

 

Oral powder 500 g (MSUD Maxamum)

Oral

 

Sachets containing oral powder 24 g, 30 (MSUD gel)

Oral

 

Sachets containing oral powder 25 g, 30 (MSUD express 15)

Oral

 

Sachets containing oral powder 34 g, 30 (MSUD express 20)

Oral

 

Sachets containing oral powder 36 g, 30 (MSUD Anamix Junior)

Oral

Amino acid formula with vitamins and minerals without valine, leucine and isoleucine with fat, carbohydrate and trace elements and supplemented with docosahexanoic acid

Oral liquid 125 mL, 36 (MSUD Anamix Junior LQ)

Oral

Amino acid formula with vitamins and minerals, low phenylalanine and supplemented with docosahexaenoic acid and arachidonic acid

Sachets containing oral powder 12.5 g, 30 (PKU Anamix First Spoon)

Oral

 

Sachets containing oral powder 12.5 g, 30 (PKU Explore 5)

Oral

 

Sachets containing oral powder 25 g, 30 (PKU Explore 10)

Oral

Amino acid formula with vitamins, minerals and long chain polyunsaturated fatty acids without phenylalanine

Oral powder 400 g (PKU Anamix infant)

Oral

 

Oral powder 400 g (PKU Start)

Oral

Amino acid formula without phenylalanine

Tablets 1 g, 75 (Phlexy‑10)

Oral

Amino acid formula without valine, leucine and isoleucine

Sachets containing oral powder 6 g, 30 (MSUD amino5)

Oral

Amino acid synthetic formula supplemented with long chain polyunsaturated fatty acids

Oral powder 400 g (EleCare LCP)

Oral

 

Oral powder 400 g (Neocate LCP)

Oral

Amino acid synthetic formula supplemented with long chain polyunsaturated fatty acids and medium chain triglycerides

Oral powder 400 g (Alfamino)

Oral

 

Oral powder 400 g (Neocate Gold)

Oral

Amino acids‑synthetic, formula

Oral powder 400 g (EleCare)

Oral

 

Oral powder 400 g (Neocate Junior Vanilla)

Oral

Amiodarone

Tablet containing amiodarone hydrochloride 100 mg

Oral

 

Tablet containing amiodarone hydrochloride 200 mg

Oral

Amisulpride

Oral solution 100 mg per mL, 60 mL

Oral

 

Tablet 100 mg

Oral

 

Tablet 200 mg

Oral

 

Tablet 400 mg

Oral

Amitriptyline

Tablet containing amitriptyline hydrochloride 10 mg

Oral

 

Tablet containing amitriptyline hydrochloride 25 mg

Oral

 

Tablet containing amitriptyline hydrochloride 50 mg

Oral

Amlodipine

Tablet 10 mg (as besilate)

Oral

 

Tablet 5 mg (as besilate)

Oral

Amlodipine with atorvastatin

Tablet 10 mg amlodipine (as besilate) with 10 mg atorvastatin (as calcium)

Oral

 

Tablet 10 mg amlodipine (as besilate) with 20 mg atorvastatin (as calcium)

Oral

 

Tablet 10 mg amlodipine (as besilate) with 40 mg atorvastatin (as calcium)

Oral

 

Tablet 10 mg amlodipine (as besilate) with 80 mg atorvastatin (as calcium)

Oral

 

Tablet 5 mg amlodipine (as besilate) with 10 mg atorvastatin (as calcium)

Oral

 

Tablet 5 mg amlodipine (as besilate) with 20 mg atorvastatin (as calcium)

Oral

 

Tablet 5 mg amlodipine (as besilate) with 40 mg atorvastatin (as calcium)

Oral

 

Tablet 5 mg amlodipine (as besilate) with 80 mg atorvastatin (as calcium)

Oral

Amlodipine with valsartan

Tablet 10 mg (as besilate)‑160 mg

Oral

 

Tablet 10 mg (as besilate)‑320 mg

Oral

 

Tablet 5 mg (as besilate)‑160 mg

Oral

 

Tablet 5 mg (as besilate)‑320 mg

Oral

 

Tablet 5 mg (as besilate)‑80 mg

Oral

Amlodipine with valsartan and hydrochlorothiazide

Tablet 10 mg (as besilate)‑160 mg‑12.5 mg

Oral

 

Tablet 10 mg (as besilate)‑160 mg‑25 mg

Oral

 

Tablet 10 mg (as besilate)‑320 mg‑25 mg

Oral

 

Tablet 5 mg (as besilate)‑160 mg‑12.5 mg

Oral

 

Tablet 5 mg (as besilate)‑160 mg‑25 mg

Oral

Amoxicillin

Capsule 250 mg (as trihydrate)

Oral

 

Capsule 500 mg (as trihydrate)

Oral

 

Powder for oral suspension 125 mg (as trihydrate) per 5 mL, 100 mL

Oral

 

Powder for oral suspension 250 mg (as trihydrate) per 5 mL, 100 mL

Oral

 

Powder for oral suspension 500 mg (as trihydrate) per 5 mL, 100 mL

Oral

 

Powder for paediatric oral drops 100 mg (as trihydrate) per mL, 20 mL

Oral

 

Tablet 1 g (as trihydrate)

Oral

Amoxicillin with clavulanic acid

Powder for oral suspension containing 125 mg amoxicillin (as trihydrate) with 31.25 mg clavulanic acid (as potassium clavulanate) per 5 mL, 75 mL

Oral

 

Powder for oral suspension containing 400 mg amoxicillin (as trihydrate) with 57 mg clavulanic acid (as potassium clavulanate) per 5 mL, 60 mL

Oral

 

Tablet containing 500 mg amoxicillin (as trihydrate) with 125 mg clavulanic acid (as potassium clavulanate)

Oral

 

Tablet containing 875 mg amoxicillin (as trihydrate) with 125 mg clavulanic acid (as potassium clavulanate)

Oral

Amphotericin B

Lozenge 10 mg

Oral

Ampicillin

Powder for injection 1 g (as sodium)

Injection

 

Powder for injection 500 mg (as sodium)

Injection

Amylopectin, modified long chain

Sachets containing oral powder 60 g, 30 (Glycosade)

Oral

Anastrozole

Tablet 1 mg

Oral

Apixaban

Tablet 2.5 mg

Oral

 

Tablet 5 mg

Oral

Apomorphine

Injection containing apomorphine hydrochloride hemihydrate 100 mg in 20 mL

Injection

 

Solution for subcutaneous injection containing apomorphine hydrochloride 30 mg in 3 mL pre-filled pen

Injection

Apraclonidine

Eye drops 5 mg (as hydrochloride) per mL, 10 mL

Application to the eye

Aprepitant

Capsule 165 mg

Oral

Arachidonic acid and docosahexaenoic acid with carbohydrate

Sachets of oral powder 4 g containing 200 mg arachidonic acid and 100 mg docosahexaenoic acid, 30 (keyomega)

Oral

Arginine with carbohydrate

Sachets of oral powder 4 g containing 2 g arginine, 30 (Arginine 2000)

Oral

 

Sachets of oral powder 4 g containing 500 mg arginine, 30 (Arginine 500)

Oral

 

Sachets of oral powder 7.6 g containing 5 g arginine, 30 (Arginine 5000)

Oral

Aripiprazole

Powder for injection 300 mg (as monohydrate) with diluent

Injection

 

Powder for injection 400 mg (as monohydrate) with diluent

Injection

 

Tablet 10 mg

Oral

 

Tablet 15 mg

Oral

 

Tablet 20 mg

Oral

 

Tablet 30 mg

Oral

Armodafinil

Tablet 150 mg

Oral

 

Tablet 250 mg

Oral

 

Tablet 50 mg

Oral

Artemether with lumefantrine

Tablet (dispersible) 20 mg‑120 mg

Oral

 

Tablet 20 mg‑120 mg

Oral

Asenapine

Sublingual wafer 10 mg (as maleate)

Sublingual

 

Sublingual wafer 5 mg (as maleate)

Sublingual

Aspirin

Tablet 100 mg

Oral

Atenolol

Oral solution 50 mg in 10 mL, 300 mL

Oral

 

Tablet 50 mg

Oral

Atomoxetine

Capsule 10 mg (as hydrochloride)

Oral

 

Capsule 100 mg (as hydrochloride)

Oral

 

Capsule 18 mg (as hydrochloride)

Oral

 

Capsule 25 mg (as hydrochloride)

Oral

 

Capsule 40 mg (as hydrochloride)

Oral

 

Capsule 60 mg (as hydrochloride)

Oral

 

Capsule 80 mg (as hydrochloride)

Oral

Atorvastatin

Tablet 10 mg (as calcium)

Oral

 

Tablet 20 mg (as calcium)

Oral

 

Tablet 40 mg (as calcium)

Oral

 

Tablet 80 mg (as calcium)

Oral

Atovaquone

Oral suspension 750 mg per 5 mL, 210 mL

Oral

Atovaquone with proguanil

Tablet containing atovaquone 250 mg with proguanil hydrochloride 100 mg

Oral

Atropine

Eye drops containing atropine sulfate monohydrate 10 mg per mL, 15 mL

Application to the eye

 

Injection containing atropine sulfate monohydrate 600 micrograms in 1 mL

Injection

Auranofin

Capsule 3 mg

Oral

 

Tablet 3 mg

Oral

Axitinib

Tablet 1 mg

Oral

 

Tablet 5 mg

Oral

Azathioprine

Tablet 25 mg

Oral

 

Tablet 50 mg

Oral

Azithromycin

Powder for oral suspension 200 mg (as dihydrate) per 5 mL, 15 mL

Oral

 

Tablet 500 mg (as dihydrate)

Oral

Baclofen

Tablet 10 mg

Oral

 

Tablet 25 mg

Oral

Balsalazide

Capsule containing balsalazide sodium 750 mg

Oral

Baricitinib

Tablet 2 mg

Oral

 

Tablet 4 mg

Oral

Beclometasone

Pressurised inhalation containing beclometasone dipropionate 100 micrograms per dose, 200 doses (CFC‑free formulation)

Inhalation by mouth

 

Pressurised inhalation containing beclometasone dipropionate 50 micrograms per dose, 200 doses (CFC‑free formulation)

Inhalation by mouth

 

Pressurised inhalation in breath actuated device containing beclometasone dipropionate 100 micrograms per dose, 200 doses (CFC‑free formulation)

Inhalation by mouth

 

Pressurised inhalation in breath actuated device containing beclometasone dipropionate 50 micrograms per dose, 200 doses (CFC‑free formulation)

Inhalation by mouth

Benzathine benzylpenicillin

Injection containing 1,200,000 units benzathine benzylpenicillin tetrahydrate in 2.3 mL single use pre‑filled syringe

Injection

 

Injection containing 600,000 units benzathine benzylpenicillin tetrahydrate in 1.17 mL single use pre‑filled syringe

Injection

Benzatropine

Injection containing benzatropine mesilate 2 mg in 2 mL

Injection

 

Tablet containing benzatropine mesilate 2 mg

Oral

Benzydamine

Mouth and throat rinse containing benzydamine hydrochloride 22.5 mg per 15 mL, 500 mL

Oral application

Benzylpenicillin

Powder for injection 3 g (as sodium)

Injection

 

Powder for injection 600 mg (as sodium)

Injection

Betaine

Oral powder 180 g

Oral

Betamethasone

Cream 200 micrograms (as valerate) per g, 100 g

Application

 

Cream 500 micrograms (as dipropionate) per g, 15 g

Application

 

Cream 500 micrograms (as valerate) per g, 15 g

Application

 

Injection containing betamethasone acetate 3 mg with betamethasone sodium phosphate 3.9 mg in 1 mL

Injection

 

Ointment 500 micrograms (as dipropionate) per g, 15 g

Application

Betaxolol

Eye drops, solution, 5 mg (as hydrochloride) per mL, 5 mL

Application to the eye

Bethanechol

Tablet containing bethanechol hydrochloride 10 mg

Oral

Bicalutamide

Tablet 50 mg

Oral

Bimatoprost

Eye drops 300 micrograms per mL, 3 mL

Application to the eye

 

Eye drops 300 micrograms per mL, single dose units 0.4 mL, 30

Application to the eye

Bimatoprost with timolol

Eye drops 300 micrograms bimatoprost with timolol 5 mg (as maleate) per mL, 3 mL

Application to the eye

 

Eye drops 300 micrograms bimatoprost with timolol 5 mg (as maleate) per mL, single dose units 0.4 mL, 30

Application to the eye

Binimetinib

Tablet 15 mg

Oral

Bisacodyl

Enemas 10 mg in 5 mL, 25

Rectal

 

Suppositories 10 mg, 10

Rectal

 

Suppositories 10 mg, 12

Rectal

 

Tablet 5 mg

Oral

Bisoprolol

Tablet containing bisoprolol fumarate 10 mg

Oral

 

Tablet containing bisoprolol fumarate 2.5 mg

Oral

 

Tablet containing bisoprolol fumarate 5 mg

Oral

Bivalirudin

Powder for I.V. injection 250 mg (as trifluoroacetate)

Injection

Brexpiprazole

Tablet 1 mg

Oral

 

Tablet 2 mg

Oral

 

Tablet 3 mg

Oral

 

Tablet 4 mg

Oral

Brigatinib

Pack containing 7 tablets 90 mg and 21 tablets 180 mg

Oral

 

Tablet 30 mg

Oral

 

Tablet 90 mg

Oral

 

Tablet 180 mg

Oral

Brimonidine

Eye drops containing brimonidine tartrate 1.5 mg per mL, 5 mL

Application to the eye

 

Eye drops containing brimonidine tartrate 2 mg per mL, 5 mL

Application to the eye

Brimonidine with timolol

Eye drops containing brimonidine tartrate 2 mg with timolol 5 mg (as maleate) per mL, 5 mL

Application to the eye

Brinzolamide

Eye drops 10 mg per mL, 5 mL

Application to the eye

Brinzolamide with brimonidine

Eye drops 10 mg brinzolamide with 2 mg brimonidine tartrate per mL, 5 mL

Application to the eye

Brinzolamide with timolol

Eye drops 10 mg brinzolamide with timolol 5 mg (as maleate) per mL, 5 mL

Application to the eye

Brivaracetam

Oral solution 10 mg per mL, 300 mL

Oral

 

Tablet 100 mg

Oral

 

Tablet 25 mg

Oral

 

Tablet 50 mg

Oral

 

Tablet 75 mg

Oral

Bromocriptine

Tablet 2.5 mg (as mesilate)

Oral

Budesonide

Nebuliser suspension 1 mg in 2 mL single dose units, 30

Inhalation

 

Nebuliser suspension 500 micrograms in 2 mL single dose units, 30

Inhalation

 

Powder for oral inhalation in breath actuated device 100 micrograms per dose, 200 doses

Inhalation by mouth

 

Powder for oral inhalation in breath actuated device 200 micrograms per dose, 200 doses

Inhalation by mouth

 

Powder for oral inhalation in breath actuated device 400 micrograms per dose, 200 doses

Inhalation by mouth

 

Rectal foam 2 mg per application, 14 applications, aerosol 16.8 g, 2

Rectal

Budesonide with formoterol

Powder for oral inhalation in breath actuated device containing budesonide 100 micrograms with formoterol fumarate dihydrate 6 micrograms per dose, 120 doses

Inhalation by mouth

 

Powder for oral inhalation in breath actuated device containing budesonide 200 micrograms with formoterol fumarate dihydrate 6 micrograms per dose, 120 doses

Inhalation by mouth

 

Powder for oral inhalation in breath actuated device containing budesonide 400 micrograms with formoterol fumarate dihydrate 12 micrograms per dose, 60 doses, 2

Inhalation by mouth

 

Pressurised inhalation containing budesonide 100 micrograms with formoterol fumarate dihydrate 3 micrograms per dose, 120 doses

Inhalation by mouth

 

Pressurised inhalation containing budesonide 200 micrograms with formoterol fumarate dihydrate 6 micrograms per dose, 120 doses

Inhalation by mouth

 

Pressurised inhalation containing budesonide 50 micrograms with formoterol fumarate dihydrate 3 micrograms per dose, 120 doses

Inhalation by mouth

Buprenorphine

Transdermal patch 10 mg

Transdermal

 

Transdermal patch 15 mg

Transdermal

 

Transdermal patch 20 mg

Transdermal

 

Transdermal patch 25 mg

Transdermal

 

Transdermal patch 30 mg

Transdermal

 

Transdermal patch 40 mg

Transdermal

 

Transdermal patch 5 mg

Transdermal

Bupropion

Tablet containing bupropion hydrochloride 150 mg (sustained release)

Oral

Busulfan

Tablet 2 mg

Oral

Cabergoline

Tablet 1 mg

Oral

 

Tablet 2 mg

Oral

 

Tablet 500 micrograms

Oral

Cabozantinib

Tablet 20 mg

Oral

 

Tablet 40 mg

Oral

 

Tablet 60 mg

Oral

Calcipotriol with betamethasone

Foam containing calcipotriol 50 micrograms with betamethasone 500 micrograms (as dipropionate) per g, 60 g

Application

 

Gel containing calcipotriol 50 micrograms with betamethasone 500 micrograms (as dipropionate) per g, 60 g

Application

 

Ointment containing calcipotriol 50 micrograms with betamethasone 500 micrograms (as dipropionate) per g, 30 g

Application

Calcitonin salmon

Injection 100 I.U. in 1 mL

Injection

Calcitriol

Capsule 0.25 microgram

Oral

Calcium

Tablet 600 mg (as carbonate)

Oral

 

Tablet, chewable, 500 mg (as carbonate)

Oral

Candesartan

Tablet containing candesartan cilexetil 16 mg

Oral

 

Tablet containing candesartan cilexetil 32 mg

Oral

 

Tablet containing candesartan cilexetil 4 mg

Oral

 

Tablet containing candesartan cilexetil 8 mg

Oral

Candesartan with hydrochlorothiazide

Tablet containing candesartan cilexetil 16 mg with hydrochlorothiazide 12.5 mg

Oral

 

Tablet containing candesartan cilexetil 32 mg with hydrochlorothiazide 12.5 mg

Oral

 

Tablet containing candesartan cilexetil 32 mg with hydrochlorothiazide 25 mg

Oral

Capecitabine

Tablet 150 mg

Oral

 

Tablet 500 mg

Oral

Captopril

Oral solution 5 mg per mL, 95 mL

Oral

 

Tablet 12.5 mg

Oral

 

Tablet 25 mg

Oral

 

Tablet 50 mg

Oral

Carbamazepine

Oral suspension 100 mg per 5 mL, 300 mL

Oral

 

Tablet 100 mg

Oral

 

Tablet 200 mg

Oral

 

Tablet 200 mg (controlled release)

Oral

 

Tablet 400 mg (controlled release)

Oral

Carbimazole

Tablet 5 mg

Oral

Carbohydrate, fat, vitamins, minerals and trace elements

Oral powder 400 g (Energivit)

Oral

Carbohydrate, fat, vitamins, minerals and trace elements and supplemented with arachidonic acid and docosahexaenoic acid

Sachets containing oral powder 43 g, 30 (basecal 200)

Oral

Carbomer

Eye gel 2 mg per g, 10 g

Application to the eye

 

Eye gel 2 mg per g, single dose units 0.6 mL, 30

Application to the eye

Carbomer 974

Ocular lubricating gel 3 mg per g, single dose units 0.5 g, 30

Application to the eye

Carmellose

Eye drops containing carmellose sodium 10 mg per mL, 15 mL

Application to the eye

 

Eye drops containing carmellose sodium 10 mg per mL, single dose units 0.4 mL, 30

Application to the eye

 

Eye drops containing carmellose sodium 5 mg per mL, 10 mL

Application to the eye

 

Eye drops containing carmellose sodium 5 mg per mL, 15 mL

Application to the eye

 

Eye drops containing carmellose sodium 5 mg per mL, single dose units 0.4 mL, 30

Application to the eye

Carmellose with glycerin

Eye drops containing carmellose sodium 5 mg with glycerin 9 mg per mL, 15 mL

Application to the eye

Carmustine

Implants 7.7 mg, 8

Implantation

Carvedilol

Tablet 12.5 mg

Oral

 

Tablet 25 mg

Oral

 

Tablet 3.125 mg

Oral

 

Tablet 6.25 mg

Oral

Cefaclor

Powder for oral suspension 125 mg (as monohydrate) per 5 mL, 100 mL

Oral

 

Powder for oral suspension 250 mg (as monohydrate) per 5 mL, 75 mL

Oral

 

Tablet (sustained release) 375 mg (as monohydrate)

Oral

Cefalexin

Capsule 250 mg (as monohydrate)

Oral

 

Capsule 500 mg (as monohydrate)

Oral

 

Granules for oral suspension 125 mg (as monohydrate) per 5 mL, 100 mL

Oral

 

Granules for oral suspension 250 mg (as monohydrate) per 5 mL, 100 mL

Oral

Cefalotin

Powder for injection 1 g (as sodium)

Injection

Cefazolin

Powder for injection 1 g (as sodium)

Injection

 

Powder for injection 2 g (as sodium)

Injection

 

Powder for injection 500 mg (as sodium)

Injection

Cefepime

Powder for injection 1 g (as hydrochloride)

Injection

 

Powder for injection 2 g (as hydrochloride)

Injection

Cefotaxime

Powder for injection 1 g (as sodium)

Injection

 

Powder for injection 2 g (as sodium)

Injection

Ceftriaxone

Powder for injection 1 g (as sodium)

Injection

 

Powder for injection 2 g (as sodium)

Injection

 

Powder for injection 500 mg (as sodium)

Injection

Cefuroxime

Powder for oral suspension 125 mg (as axetil) per 5 mL, 100 mL

Oral

 

Powder for oral suspension 125 mg (as axetil) per 5 mL, 70 mL

Oral

 

Tablet 250 mg (as axetil)

Oral

Celecoxib

Capsule 100 mg

Oral

 

Capsule 200 mg

Oral

Ceritinib

Capsule 150 mg

Oral

Certolizumab pegol

Injection 200 mg in 1 mL single use pre‑filled syringe

Injection

 

Solution for injection 200 mg in 1 mL pre‑filled pen

Injection

Chlorambucil

Tablet 2 mg

Oral

Chloramphenicol

Eye drops 5 mg per mL, 10 mL

Application to the eye

Chlorpromazine

Injection containing chlorpromazine hydrochloride 50 mg in 2 mL

Injection

 

Oral solution containing chlorpromazine hydrochloride 25 mg per 5 mL, 100 mL

Oral

 

Tablet containing chlorpromazine hydrochloride 10 mg

Oral

 

Tablet containing chlorpromazine hydrochloride 100 mg

Oral

 

Tablet containing chlorpromazine hydrochloride 25 mg

Oral

Chlortalidone

Tablet 25 mg

Oral

Chorionic gonadotrophin

Injection set containing powder for injection 1,500 units, 3 and solvent 1 mL, 3

Injection

Ciclesonide

Pressurised inhalation 160 micrograms per dose, 120 doses (CFC‑free formulation)

Inhalation by mouth

 

Pressurised inhalation 80 micrograms per dose, 120 doses (CFC‑free formulation)

Inhalation by mouth

Ciclosporin

Capsule 10 mg

Oral

 

Capsule 100 mg

Oral

 

Capsule 25 mg

Oral

 

Capsule 50 mg

Oral

 

Oral liquid 100 mg per mL, 50 mL

Oral

Cimetidine

Tablet 400 mg

Oral

Cinacalcet

Tablet 30 mg (as hydrochloride)

Oral

 

Tablet 60 mg (as hydrochloride)

Oral

 

Tablet 90 mg (as hydrochloride)

Oral

Ciprofloxacin

Ear drops 3 mg (as hydrochloride) per mL, 5 mL

Application to the ear

 

Eye drops 3 mg (as hydrochloride) per mL, 5 mL

Application to the eye

 

Tablet 250 mg (as hydrochloride)

Oral

 

Tablet 500 mg (as hydrochloride)

Oral

 

Tablet 750 mg (as hydrochloride)

Oral

Citalopram

Tablet 10 mg (as hydrobromide)

Oral

 

Tablet 20 mg (as hydrobromide)

Oral

 

Tablet 40 mg (as hydrobromide)

Oral

Citrulline

Tablet 1 g, 300 (Citrulline Easy)

Oral

Citrulline with carbohydrate

Sachets of oral powder 4 g containing 1 g citrulline, 30 (Citrulline 1000)

Oral

Cladribine

Tablet 10 mg

Oral

Clarithromycin

Powder for oral liquid 250 mg per 5 mL, 50 mL

Oral

 

Tablet 250 mg

Oral

Clindamycin

Capsule 150 mg (as hydrochloride)

Oral

Clobetasol

Shampoo containing clobetasol propionate 500 microgram per mL, 125 mL

Application

Clomifene

Tablet containing clomifene citrate 50 mg

Oral

Clomipramine

Tablet containing clomipramine hydrochloride 25 mg

Oral

Clonazepam

Injection 1 mg in 2 mL (set containing solution 1 mg in 1 mL and 1 mL diluent)

Injection

 

Oral liquid 2.5 mg per mL, 10 mL

Oral

 

Tablet 2 mg

Oral

 

Tablet 500 micrograms

Oral

Clonidine

Tablet containing clonidine hydrochloride 100 micrograms

Oral

 

Tablet containing clonidine hydrochloride 150 micrograms

Oral

Clopidogrel

Tablet 75 mg (as besilate)

Oral

 

Tablet 75 mg (as hydrogen sulfate)

Oral

Clopidogrel with aspirin

Tablet 75 mg (as hydrogen sulfate)‑100 mg

Oral

Cobimetinib

Tablet 20 mg

Oral

Codeine

Tablet containing codeine phosphate hemihydrate 30 mg

Oral

Codeine with paracetamol

Tablet containing codeine phosphate hemihydrate 30 mg with paracetamol 500 mg

Oral

Colchicine

Tablet 500 micrograms

Oral

Colestyramine

Sachets containing 4.7 g oral powder (equivalent to 4 g colestyramine), 50

Oral

Cortisone

Tablet containing cortisone acetate 25 mg

Oral

 

Tablet containing cortisone acetate 5 mg

Oral

Crizotinib

Capsule 200 mg

Oral

 

Capsule 250 mg

Oral

Cromoglycic acid

Pressurised inhalation containing sodium cromoglycate 1 mg per dose, 200 doses (CFC‑free formulation)

Inhalation by mouth

 

Pressurised inhalation containing sodium cromoglycate 5 mg per dose, 112 doses (CFC‑free formulation)

Inhalation by mouth

Cyclophosphamide

Tablet 50 mg (anhydrous)

Oral

Cyproterone

Tablet containing cyproterone acetate 100 mg

Oral

 

Tablet containing cyproterone acetate 50 mg

Oral

Dabigatran etexilate

Capsule 110 mg (as mesilate)

Oral

 

Capsule 150 mg (as mesilate)

Oral

 

Capsule 75 mg (as mesilate)

Oral

Dabrafenib

Capsule 50 mg (as mesilate)

Oral

 

Capsule 75 mg (as mesilate)

Oral

Dalteparin

Injection containing dalteparin sodium 10,000 I.U. (anti‑Xa) in 1 mL single dose pre‑filled syringe

Injection

 

Injection containing dalteparin sodium 12,500 I.U. (anti‑Xa) in 0.5 mL single dose pre‑filled syringe

Injection

 

Injection containing dalteparin sodium 15,000 I.U. (anti‑Xa) in 0.6 mL single dose pre‑filled syringe

Injection

 

Injection containing dalteparin sodium 18,000 I.U. (anti‑Xa) in 0.72 mL single dose pre‑filled syringe

Injection

 

Injection containing dalteparin sodium 2,500 I.U. (anti‑Xa) in 0.2 mL single dose pre‑filled syringe

Injection

 

Injection containing dalteparin sodium 5,000 I.U. (anti‑Xa) in 0.2 mL single dose pre‑filled syringe

Injection

 

Injection containing dalteparin sodium 7,500 I.U. (anti‑Xa) in 0.75 mL single dose pre‑filled syringe

Injection

Dantrolene

Capsule containing dantrolene sodium hemiheptahydrate 25 mg

Oral

 

Capsule containing dantrolene sodium hemiheptahydrate 50 mg

Oral

Dapagliflozin

Tablet 10 mg (as propanediol monohydrate)

Oral

Dapagliflozin with metformin

Tablet (modified release) containing 10 mg dapagliflozin (as propanediol monohydrate) with 1000 mg metformin hydrochloride

Oral

 

Tablet (modified release) containing 10 mg dapagliflozin (as propanediol monohydrate) with 500 mg metformin hydrochloride

Oral

 

Tablet (modified release) containing 5 mg dapagliflozin (as propanediol monohydrate) with 1000 mg metformin hydrochloride

Oral

Dapsone

Tablet 100 mg

Oral

 

Tablet 25 mg

Oral

Dasatinib

Tablet 100 mg

Oral

 

Tablet 20 mg

Oral

 

Tablet 50 mg

Oral

 

Tablet 70 mg

Oral

Degarelix

Powder for injection 120 mg (as acetate), 2, injection set

Injection

 

Powder for injection 80 mg (as acetate), injection set

Injection

Denosumab

Injection 120 mg in 1.7 mL

Injection

 

Injection 60 mg in 1 mL pre‑filled syringe

Injection

Desmopressin

Intranasal solution containing desmopressin acetate 100 micrograms per mL, 2.5 mL dropper bottle

Nasal

 

Nasal spray (pump pack) containing desmopressin acetate 10 micrograms per actuation, 60 actuations, 6 mL

Nasal

 

Tablet containing desmopressin acetate 200 micrograms

Oral

 

Wafer 120 micrograms (as acetate)

Sublingual

 

Wafer 240 micrograms (as acetate)

Sublingual

Desvenlafaxine

Tablet (extended release) 100 mg (as succinate)

Oral

 

Tablet (extended release) 50 mg (as succinate)

Oral

 

Tablet (modified release) 100 mg

Oral

 

Tablet (modified release) 100 mg (as benzoate)

Oral

 

Tablet (modified release) 50 mg

Oral

 

Tablet (modified release) 50 mg (as benzoate)

Oral

Dexamethasone

Eye drops 1 mg per mL, 5 mL

Application to the eye

 

Intravitreal injection 700 micrograms

Implantation

 

Tablet 4 mg

Oral

 

Tablet 500 micrograms

Oral

Dexamethasone with framycetin and gramicidin

Ear drops containing dexamethasone 500 micrograms (as sodium metasulfobenzoate), framycetin sulfate 5 mg and gramicidin 50 micrograms per mL, 8 mL

Application to the ear

Dexamfetamine

Tablet containing dexamfetamine sulfate 5 mg

Oral

Diazepam

Oral liquid 1 mg in 1 mL, 100 mL

Oral

 

Tablet 2 mg

Oral

 

Tablet 5 mg

Oral

Diclofenac

Suppository containing diclofenac sodium 100 mg

Rectal

 

Tablet (enteric coated) containing diclofenac sodium 25 mg

Oral

 

Tablet (enteric coated) containing diclofenac sodium 50 mg

Oral

Dicloxacillin

Capsule 250 mg (as sodium)

Oral

 

Capsule 500 mg (as sodium)

Oral

Digoxin

Paediatric oral solution 50 micrograms per mL, 60 mL

Oral

 

Tablet 250 micrograms

Oral

 

Tablet 62.5 micrograms

Oral

Diltiazem

Capsule (controlled delivery) containing diltiazem hydrochloride 180 mg

Oral

 

Capsule (controlled delivery) containing diltiazem hydrochloride 240 mg

Oral

 

Capsule (controlled delivery) containing diltiazem hydrochloride 360 mg

Oral

 

Tablet containing diltiazem hydrochloride 60 mg

Oral

Dimethyl fumarate

Capsule (modified release) 120 mg

Oral

 

Capsule (modified release) 240 mg

Oral

Diphenoxylate with atropine

Tablet containing diphenoxylate hydrochloride 2.5 mg with atropine sulfate monohydrate 25 micrograms

Oral

Diphtheria and tetanus vaccine, adsorbed, diluted for adult use

Injection 0.5 mL in pre‑filled syringe

Injection

Dipyridamole with aspirin

Capsule 200 mg (sustained release)‑25 mg

Oral

Disopyramide

Capsule 100 mg

Oral

Docosahexaenoic acid with carbohydrate

Sachets of oral powder 4 g containing 200 mg docosahexaenoic acid, 30 (docomega)

Oral

Domperidone

Tablet 10 mg

Oral

Donepezil

Tablet containing donepezil hydrochloride 10 mg

Oral

 

Tablet containing donepezil hydrochloride 5 mg

Oral

Dorzolamide

Eye drops 20 mg (as hydrochloride) per mL, 5 mL

Application to the eye

Dorzolamide with timolol

Eye drops containing dorzolamide 20 mg (as hydrochloride) with timolol 5 mg (as maleate) per mL, 5 mL

Application to the eye

Dosulepin

Capsule containing dosulepin hydrochloride 25 mg

Oral

 

Tablet containing dosulepin hydrochloride 75 mg

Oral

Doxepin

Capsule 10 mg (as hydrochloride)

Oral

 

Capsule 25 mg (as hydrochloride)

Oral

 

Tablet 50 mg (as hydrochloride)

Oral

Doxycycline

Capsule 100 mg (as hyclate) (containing enteric coated pellets)

Oral

 

Capsule 50 mg (as hyclate) (containing enteric coated pellets)

Oral

 

Tablet 100 mg (as hyclate)

Oral

 

Tablet 100 mg (as monohydrate)

Oral

 

Tablet 50 mg (as hyclate)

Oral

 

Tablet 50 mg (as monohydrate)

Oral

Dulaglutide

Injection 1.5 mg in 0.5 mL single dose pre‑filled pen

Injection

Duloxetine

Capsule 30 mg (as hydrochloride)

Oral

 

Capsule 60 mg (as hydrochloride)

Oral

Dutasteride

Capsule 500 micrograms

Oral

Dutasteride with tamsulosin

Capsule containing dutasteride 500 micrograms with tamsulosin hydrochloride 400 micrograms

Oral

Electrolyte replacement, oral

Oral rehydration salts containing glucose monohydrate 3.56 g, sodium chloride 470 mg, potassium chloride 300 mg and sodium acid citrate 530 mg per sachet, 10

Oral

Eletriptan

Tablet 40 mg (as hydrobromide)

Oral

 

Tablet 80 mg (as hydrobromide)

Oral

Empagliflozin

Tablet 10 mg

Oral

 

Tablet 25 mg

Oral

Empagliflozin with linagliptin

Tablet containing 10 mg empagliflozin with 5 mg linagliptin

Oral

 

Tablet containing 25 mg empagliflozin with 5 mg linagliptin

Oral

Empagliflozin with metformin

Tablet containing 12.5 mg empagliflozin with 1 g metformin hydrochloride

Oral

 

Tablet containing 12.5 mg empagliflozin with 500 mg metformin hydrochloride

Oral

 

Tablet containing 5 mg empagliflozin with 1 g metformin hydrochloride

Oral

 

Tablet containing 5 mg empagliflozin with 500 mg metformin hydrochloride

Oral

Enalapril

Tablet containing enalapril maleate 10 mg

Oral

 

Tablet containing enalapril maleate 20 mg

Oral

 

Tablet containing enalapril maleate 5 mg

Oral

Enalapril with hydrochlorothiazide

Tablet containing enalapril maleate 20 mg with hydrochlorothiazide 6 mg

Oral

Encorafenib

Capsule 50 mg

Oral

 

Capsule 75 mg

Oral

Enoxaparin

Injection containing enoxaparin sodium 100 mg (10,000 I.U. anti‑Xa) in 1 mL pre‑filled syringe

Injection

 

Injection containing enoxaparin sodium 20 mg (2,000 I.U. anti‑Xa) in 0.2 mL pre‑filled syringe

Injection

 

Injection containing enoxaparin sodium 40 mg (4,000 I.U. anti‑Xa) in 0.4 mL pre‑filled syringe

Injection

 

Injection containing enoxaparin sodium 60 mg (6,000 I.U. anti‑Xa) in 0.6 mL pre‑filled syringe

Injection

 

Injection containing enoxaparin sodium 80 mg (8,000 I.U. anti‑Xa) in 0.8 mL pre‑filled syringe

Injection

Entacapone

Tablet 200 mg

Oral

Entrectinib

Capsule 200 mg

Oral

Enzalutamide

Capsule 40 mg

Oral

Eplerenone

Tablet 25 mg

Oral

 

Tablet 50 mg

Oral

Eprosartan

Tablet 400 mg (as mesilate)

Oral

 

Tablet 600 mg (as mesilate)

Oral

Eprosartan with hydrochlorothiazide

Tablet 600 mg eprosartan (as mesilate) with 12.5 mg hydrochlorothiazide

Oral

Eptifibatide

Solution for I.V. infusion 75 mg (as acetate) in 100 mL

Injection

 

Solution for I.V. injection 20 mg (as acetate) in 10 mL

Injection

Erlotinib

Tablet 100 mg (as hydrochloride)

Oral

 

Tablet 150 mg (as hydrochloride)

Oral

 

Tablet 25 mg (as hydrochloride)

Oral

Ertugliflozin

Tablet 15 mg

Oral

 

Tablet 5 mg

Oral

Ertugliflozin with metformin

Tablet containing 2.5 mg ertugliflozin with 1 g metformin hydrochloride

Oral

 

Tablet containing 2.5 mg ertugliflozin with 500 mg metformin hydrochloride

Oral

 

Tablet containing 7.5 mg ertugliflozin with 1 g metformin hydrochloride

Oral

 

Tablet containing 7.5 mg ertugliflozin with 500 mg metformin hydrochloride

Oral

Ertugliflozin with sitagliptin

Tablet containing 15 mg ertugliflozin with 100 mg sitagliptin

Oral

 

Tablet containing 5 mg ertugliflozin with 100 mg sitagliptin

Oral

Erythromycin

Capsule 250 mg (containing enteric coated pellets)

Oral

 

Powder for oral liquid 200 mg (as ethyl succinate) per 5 mL, 100 mL

Oral

 

Powder for oral liquid 400 mg (as ethyl succinate) per 5 mL, 100 mL

Oral

 

Tablet 400 mg (as ethyl succinate)

Oral

Escitalopram

Oral solution 20 mg (as oxalate) per mL, 15 mL

Oral

 

Tablet 10 mg (as oxalate)

Oral

 

Tablet 20 mg (as oxalate)

Oral

Esomeprazole

Capsule (enteric) 20 mg (as magnesium)

Oral

 

Capsule (enteric) 40 mg (as magnesium)

Oral

 

Tablet (enteric coated) 20 mg (as magnesium trihydrate)

Oral

 

Tablet (enteric coated) 40 mg (as magnesium trihydrate)

Oral

Esomeprazole and clarithromycin and amoxicillin

Pack containing 14 tablets (enteric coated) containing esomeprazole 20 mg (as magnesium trihydrate), 14 tablets clarithromycin 500 mg and 28 capsules amoxicillin 500 mg (as trihydrate)

Oral

 

Pack containing 14 tablets (enteric coated) containing esomeprazole 20 mg (as magnesium), 14 tablets clarithromycin 500 mg and 28 capsules amoxicillin 500 mg (as trihydrate)

Oral

Essential amino acids formula

Oral powder 200 g (Essential Amino Acid Mix)

Oral

Essential amino acids formula with minerals and vitamin c

Oral powder 400 g (Dialamine)

Oral

Essential amino acids formula with vitamins and minerals

Sachets containing oral powder 12.5 g, 50 (EAA Supplement)

Oral

Estradiol

Pessary (modified release) 10 micrograms (as hemihydrate)

Vaginal

 

Tablet 2 mg

Oral

 

Tablet containing estradiol valerate 1 mg

Oral

 

Tablet containing estradiol valerate 2 mg

Oral

 

Transdermal gel 1 mg (as hemihydrate) in 1 g sachet, 28

Transdermal

 

Transdermal patches 1.17 mg, 8

Transdermal

 

Transdermal patches 1.5 mg (as hemihydrate), 8

Transdermal

 

Transdermal patches 1.56 mg, 8

Transdermal

 

Transdermal patches 2 mg, 4

Transdermal

 

Transdermal patches 3 mg (as hemihydrate), 8

Transdermal

 

Transdermal patches 3.8 mg, 4

Transdermal

 

Transdermal patches 390 micrograms, 8

Transdermal

 

Transdermal patches 5.7 mg, 4

Transdermal

 

Transdermal patches 585 micrograms, 8

Transdermal

 

Transdermal patches 7.6 mg, 4

Transdermal

 

Transdermal patches 750 micrograms (as hemihydrate), 8

Transdermal

 

Transdermal patches 780 micrograms, 8

Transdermal

Estradiol and estradiol with dydrogesterone

Pack containing 14 tablets estradiol 1 mg and 14 tablets estradiol 1 mg with dydrogesterone 10 mg

Oral

 

Pack containing 14 tablets estradiol 2 mg and 14 tablets estradiol 2 mg with dydrogesterone 10 mg

Oral

Estradiol and estradiol with norethisterone

Pack containing 4 transdermal patches 780 micrograms estradiol (as hemihydrate) and 4 transdermal patches 510 micrograms estradiol (as hemihydrate) with 4.8 mg norethisterone acetate

Transdermal

 

Pack containing 4 transdermal patches 780 micrograms estradiol (as hemihydrate) and 4 transdermal patches 620 micrograms estradiol (as hemihydrate) with 2.7 mg norethisterone acetate

Transdermal

Estradiol with dydrogesterone

Tablet 1 mg‑5 mg

Oral

Estradiol with norethisterone

Transdermal patches containing 510 micrograms estradiol (as hemihydrate) with 4.8 mg norethisterone acetate, 8

Transdermal

 

Transdermal patches containing 620 micrograms estradiol (as hemihydrate) with 2.7 mg norethisterone acetate, 8

Transdermal

Estriol

Pessaries 500 micrograms, 15

Vaginal

 

Vaginal cream 1 mg per g, 15 g

Application

Etacrynic acid

Tablet 25 mg

Oral

Etanercept

Injection 50 mg in 1 mL single use auto‑injector, 4

Injection

 

Injection set containing 4 vials powder for injection 25 mg and 4 pre‑filled syringes solvent 1 mL

Injection

 

Injections 50 mg in 1 mL single use pre‑filled syringes, 4

Injection

Ethosuximide

Capsule 250 mg

Oral

 

Oral solution 250 mg per 5 mL, 200 mL

Oral

Etonogestrel

Subcutaneous implant 68 mg

Implantation

Etoposide

Capsule 100 mg

Oral

 

Capsule 50 mg

Oral

Everolimus

Tablet 0.25 mg

Oral

 

Tablet 0.5 mg

Oral

 

Tablet 0.75 mg

Oral

 

Tablet 1 mg

Oral

 

Tablet 10 mg

Oral

 

Tablet 2.5 mg

Oral

 

Tablet 5 mg

Oral

 

Tablet, dispersible, 2 mg

Oral

 

Tablet, dispersible, 3 mg

Oral

 

Tablet, dispersible, 5 mg

Oral

Evolocumab

Injection 140 mg in 1 mL single use pre‑filled pen

Injection

 

Injection 420 mg in 3.5 mL single use pre‑filled cartridge

Injection

Exemestane

Tablet 25 mg

Oral

Exenatide

Injection (modified release) 2 mg single dose pre‑filled pen

Injection

 

Injection solution 10 micrograms per dose in pre‑filled pen, 60 doses

Injection

 

Injection solution 5 micrograms per dose in pre‑filled pen, 60 doses

Injection

Ezetimibe

Tablet 10 mg

Oral

Ezetimibe and rosuvastatin

Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 10 mg (as calcium)

Oral

 

Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 20 mg (as calcium)

Oral

 

Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 40 mg (as calcium)

Oral

 

Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 5 mg (as calcium)

Oral

Ezetimibe with atorvastatin

Tablet 10 mg‑10 mg

Oral

 

Tablet 10 mg‑20 mg

Oral

 

Tablet 10 mg‑40 mg

Oral

 

Tablet 10 mg‑80 mg

Oral

Ezetimibe with simvastatin

Tablet 10 mg‑10 mg

Oral

 

Tablet 10 mg‑20 mg

Oral

 

Tablet 10 mg‑40 mg

Oral

 

Tablet 10 mg‑80 mg

Oral

Famciclovir

Tablet 125 mg

Oral

 

Tablet 250 mg

Oral

 

Tablet 500 mg

Oral

Famotidine

Tablet 20 mg

Oral

 

Tablet 40 mg

Oral

Febuxostat

Tablet 80 mg

Oral

Felodipine

Tablet 10 mg (extended release)

Oral

 

Tablet 2.5 mg (extended release)

Oral

 

Tablet 5 mg (extended release)

Oral

Fenofibrate

Tablet 145 mg

Oral

 

Tablet 48 mg

Oral

Fentanyl

Lozenge 1200 micrograms (as citrate)

Buccal

 

Lozenge 1600 micrograms (as citrate)

Buccal

 

Lozenge 200 micrograms (as citrate)

Buccal

 

Lozenge 400 micrograms (as citrate)

Buccal

 

Lozenge 600 micrograms (as citrate)

Buccal

 

Lozenge 800 micrograms (as citrate)

Buccal

 

Tablet (orally disintegrating) 100 micrograms (as citrate)

Buccal

 

Tablet (orally disintegrating) 200 micrograms (as citrate)

Buccal

 

Tablet (orally disintegrating) 400 micrograms (as citrate)

Buccal

 

Tablet (orally disintegrating) 600 micrograms (as citrate)

Buccal

 

Tablet (orally disintegrating) 800 micrograms (as citrate)

Buccal

 

Tablet (sublingual) 100 micrograms (as citrate)

Sublingual

 

Tablet (sublingual) 200 micrograms (as citrate)

Sublingual

 

Tablet (sublingual) 300 micrograms (as citrate)

Sublingual

 

Tablet (sublingual) 400 micrograms (as citrate)

Sublingual

 

Tablet (sublingual) 600 micrograms (as citrate)

Sublingual

 

Tablet (sublingual) 800 micrograms (as citrate)

Sublingual

 

Transdermal patch 1.28 mg

Transdermal

 

Transdermal patch 10.20 mg

Transdermal

 

Transdermal patch 12.375 mg

Transdermal

 

Transdermal patch 12.6 mg

Transdermal

 

Transdermal patch 16.5 mg

Transdermal

 

Transdermal patch 16.8 mg

Transdermal

 

Transdermal patch 2.063 mg

Transdermal

 

Transdermal patch 2.1 mg

Transdermal

 

Transdermal patch 2.55 mg

Transdermal

 

Transdermal patch 4.125 mg

Transdermal

 

Transdermal patch 4.2 mg

Transdermal

 

Transdermal patch 5.10 mg

Transdermal

 

Transdermal patch 7.65 mg

Transdermal

 

Transdermal patch 8.25 mg

Transdermal

 

Transdermal patch 8.4 mg

Transdermal

Ferric carboxymaltose

Injection 1000 mg (iron) in 20 mL

Injection

 

Injection 500 mg (iron) in 10 mL

Injection

Ferric derisomaltose

Injection 500 mg (iron) in 5 mL

Injection

 

Injection 1000 mg (iron) in 10 mL

Injection

Ferrous fumarate

Tablet 200 mg (equivalent to 65.7 mg iron)

Oral

Ferrous fumarate with folic acid

Tablet 310 mg (equivalent to 100 mg iron)‑350 micrograms

Oral

Ferrous sulfate

Oral liquid containing 30 mg ferrous sulfate heptahydrate per mL, 250 mL

Oral

Fingolimod

Capsule 250 micrograms (as hydrochloride)

Oral

 

Capsule 500 micrograms (as hydrochloride)

Oral

Flecainide

Tablet containing flecainide acetate 100 mg

Oral

 

Tablet containing flecainide acetate 50 mg

Oral

Flucloxacillin

Capsule 250 mg (as sodium monohydrate)

Oral

 

Capsule 500 mg (as sodium monohydrate)

Oral

 

Powder for injection 1 g (as sodium monohydrate)

Injection

 

Powder for oral liquid 125 mg (as sodium monohydrate) per 5 mL, 100 mL

Oral

 

Powder for oral liquid 250 mg (as sodium monohydrate) per 5 mL, 100 mL

Oral

Fluconazole

Capsule 100 mg

Oral

 

Capsule 200 mg

Oral

 

Capsule 50 mg

Oral

 

Powder for oral suspension 50 mg in 5 mL, 35 mL

Oral

 

Solution for I.V. infusion 200 mg in 100 mL

Injection

 

Solution for I.V. infusion 400 mg in 200 mL

Injection

Fludarabine

Tablet containing fludarabine phosphate 10 mg

Oral

Fludrocortisone

Tablet containing fludrocortisone acetate 100 micrograms

Oral

Fluorometholone

Eye drops 1 mg per mL, 5 mL

Application to the eye

 

Eye drops containing fluorometholone acetate 1 mg per mL, 5 mL

Application to the eye

Fluoxetine

Capsule 20 mg (as hydrochloride)

Oral

 

Tablet, dispersible, 20 mg (as hydrochloride)

Oral

Flupentixol decanoate

Oily I.M. injection 100 mg in 1 mL

Injection

 

Oily I.M. injection 20 mg in 1 mL

Injection

Flutamide

Tablet 250 mg

Oral

Fluticasone furoate

Powder for oral inhalation in breath actuated device containing fluticasone furoate 100 micrograms per dose, 30 doses

Inhalation by mouth

 

Powder for oral inhalation in breath actuated device containing fluticasone furoate 200 micrograms per dose, 30 doses

Inhalation by mouth

Fluticasone furoate with umeclidinium and vilanterol

Powder for oral inhalation in breath actuated device containing fluticasone furoate 100 micrograms with umeclidinium 62.5 micrograms (as bromide) and vilanterol 25 micrograms (as trifenatate) per dose, 30 doses

Inhalation by mouth

Fluticasone furoate with vilanterol

Powder for oral inhalation in breath actuated device containing fluticasone furoate 100 micrograms with vilanterol 25 micrograms (as trifenatate) per dose, 30 doses

Inhalation by mouth

 

Powder for oral inhalation in breath actuated device containing fluticasone furoate 200 micrograms with vilanterol 25 micrograms (as trifenatate) per dose, 30 doses

Inhalation by mouth

Fluticasone propionate

Powder for oral inhalation in breath actuated device containing fluticasone propionate 100 micrograms per dose, 60 doses

Inhalation by mouth

 

Powder for oral inhalation in breath actuated device containing fluticasone propionate 250 micrograms per dose, 60 doses

Inhalation by mouth

 

Powder for oral inhalation in breath actuated device containing fluticasone propionate 500 micrograms per dose, 60 doses

Inhalation by mouth

 

Pressurised inhalation containing fluticasone propionate 125 micrograms per dose, 120 doses (CFC‑free formulation)

Inhalation by mouth

 

Pressurised inhalation containing fluticasone propionate 250 micrograms per dose, 120 doses (CFC‑free formulation)

Inhalation by mouth

 

Pressurised inhalation containing fluticasone propionate 50 micrograms per dose, 120 doses (CFC‑free formulation)

Inhalation by mouth

Fluticasone propionate with formoterol

Pressurised inhalation containing fluticasone propionate 125 micrograms with formoterol fumarate dihydrate 5 micrograms per dose, 120 doses

Inhalation by mouth

 

Pressurised inhalation containing fluticasone propionate 250 micrograms with formoterol fumarate dihydrate 10 micrograms per dose, 120 doses

Inhalation by mouth

 

Pressurised inhalation containing fluticasone propionate 50 micrograms with formoterol fumarate dihydrate 5 micrograms per dose, 120 doses

Inhalation by mouth

Fluticasone propionate with salmeterol

Powder for oral inhalation in breath actuated device containing fluticasone propionate 100 micrograms with salmeterol 50 micrograms (as xinafoate) per dose, 60 doses

Inhalation by mouth

 

Powder for oral inhalation in breath actuated device containing fluticasone propionate 250 micrograms with salmeterol 50 micrograms (as xinafoate) per dose, 60 doses

Inhalation by mouth

 

Powder for oral inhalation in breath actuated device containing fluticasone propionate 500 micrograms with salmeterol 50 micrograms (as xinafoate) per dose, 60 doses

Inhalation by mouth

 

Pressurised inhalation containing fluticasone propionate 125 micrograms with salmeterol 25 micrograms (as xinafoate) per dose, 120 doses (CFC‑free formulation)

Inhalation by mouth

 

Pressurised inhalation containing fluticasone propionate 250 micrograms with salmeterol 25 micrograms (as xinafoate) per dose, 120 doses (CFC‑free formulation)

Inhalation by mouth

 

Pressurised inhalation containing fluticasone propionate 50 micrograms with salmeterol 25 micrograms (as xinafoate) per dose, 120 doses (CFC‑free formulation)

Inhalation by mouth

Fluvastatin

Tablet (prolonged release) 80 mg (as sodium)

Oral

Fluvoxamine

Tablet containing fluvoxamine maleate 100 mg

Oral

 

Tablet containing fluvoxamine maleate 50 mg

Oral

Folic acid

Tablet 5 mg

Oral

 

Tablet 500 micrograms

Oral

Folinic acid

Injection containing calcium folinate equivalent to 100 mg folinic acid in 10 mL

Injection

 

Injection containing calcium folinate equivalent to 300 mg folinic acid in 30 mL

Injection

 

Injection containing calcium folinate equivalent to 50 mg folinic acid in 5 mL

Injection

 

Tablet containing calcium folinate equivalent to 15 mg folinic acid

Oral

Follitropin alfa

Injection 150 I.U. in 0.25 mL pre‑filled pen

Injection

 

Injection 225 I.U. in 0.375 mL pre‑filled pen

Injection

 

Injection 300 I.U. in 0.5 mL multi‑dose cartridge

Injection

 

Injection 450 I.U. in 0.75 mL multi‑dose cartridge

Injection

 

Injection 75 I.U. in 0.125 mL pre‑filled pen

Injection

 

Injection 900 I.U. in 1.5 mL multi‑dose cartridge

Injection

Follitropin beta

Solution for injection 300 I.U. in 0.36 mL multi‑dose cartridge

Injection

 

Solution for injection 600 I.U. in 0.72 mL multi‑dose cartridge

Injection

 

Solution for injection 900 I.U. in 1.08 mL multi‑dose cartridge

Injection

Fondaparinux

Injection containing fondaparinux sodium 2.5 mg in 0.5 mL single dose pre‑filled syringe

Injection

Formoterol

Capsule containing powder for oral inhalation containing formoterol fumarate dihydrate 12 micrograms (for use in Foradile Aerolizer)

Inhalation by mouth

 

Powder for oral inhalation in breath actuated device containing formoterol fumarate dihydrate 12 micrograms per dose, 60 doses

Inhalation by mouth

 

Powder for oral inhalation in breath actuated device containing formoterol fumarate dihydrate 6 micrograms per dose, 60 doses

Inhalation by mouth

Fosaprepitant

Powder for I.V. infusion 150 mg

Injection

Fosinopril

Tablet containing fosinopril sodium 10 mg

Oral

 

Tablet containing fosinopril sodium 20 mg

Oral

Fosinopril with hydrochlorothiazide

Tablet containing fosinopril sodium 20 mg with hydrochlorothiazide 12.5 mg

Oral

Framycetin

Eye or ear drops containing framycetin sulfate 5 mg per mL, 8 mL

Application to the eye/ear

Furosemide

Injection 20 mg in 2 mL

Injection

 

Oral solution 10 mg per mL, 30 mL

Oral

 

Tablet 20 mg

Oral

 

Tablet 40 mg

Oral

 

Tablet 500 mg

Oral

Fusidic acid

Tablet containing sodium fusidate 250 mg

Oral

Gabapentin

Capsule 100 mg

Oral

 

Capsule 300 mg

Oral

 

Capsule 400 mg

Oral

 

Tablet 600 mg

Oral

 

Tablet 800 mg

Oral

Galantamine

Capsule (prolonged release) 16 mg (as hydrobromide)

Oral

 

Capsule (prolonged release) 24 mg (as hydrobromide)

Oral

 

Capsule (prolonged release) 8 mg (as hydrobromide)

Oral

Gefitinib

Tablet 250 mg

Oral

Gemfibrozil

Tablet 600 mg

Oral

Gentamicin

Eye drops 3 mg (as sulfate) per mL, 5 mL

Application to the eye

 

Injection 80 mg (as sulfate) in 2 mL

Injection

Glatiramer

Injection containing glatiramer acetate 40 mg in 1 mL single dose pre‑filled syringe

Injection

Glecaprevir with pibrentasvir

Tablet containing 100 mg glecaprevir with 40 mg pibrentasvir

Oral

Glibenclamide

Tablet 5 mg

Oral

Gliclazide

Tablet 30 mg (modified release)

Oral

 

Tablet 60 mg (modified release)

Oral

 

Tablet 80 mg

Oral

Glimepiride

Tablet 1 mg

Oral

 

Tablet 2 mg

Oral

 

Tablet 3 mg

Oral

 

Tablet 4 mg

Oral

Glipizide

Tablet 5 mg

Oral

Glucagon

Injection set containing glucagon hydrochloride 1 mg (1 I.U.) and 1 mL solvent in disposable syringe

Injection

Glucose and ketone indicator‑urine

Test strips, 50 (Keto‑Diastix)

For external use

Glucose indicator‑urine

Test strips, 50 (Diastix)

For external use

Glyceryl trinitrate

Sublingual spray (pump pack) 400 micrograms per dose, 200 doses

Sublingual

 

Transdermal patch 18 mg

Transdermal

 

Transdermal patch 25 mg

Transdermal

 

Transdermal patch 36 mg

Transdermal

 

Transdermal patch 50 mg

Transdermal

 

Transdermal patch 54 mg

Transdermal

Glycine with carbohydrate

Sachets of oral powder 4 g containing 500 mg glycine, 30 (Glycine500)

Oral

Glycomacropeptide and essential amino acid formula with vitamins, minerals, and low in tyrosine and phenylalanine

Sachets containing oral powder 31 g, 30 (Tylactin Build 20)

Oral

 

Sachets containing oral powder 35 g, 30 (TYR Sphere20)

Oral

Glycomacropeptide and essential amino acids with vitamins and minerals

Bars 81 g, 14 (Tylactin Complete)

Oral

 

Bars 81 g, 7 (Camino Pro Complete)

Oral

 

Oral liquid 250 mL, 30 (PKU Glytactin RTD 15 Lite)

Oral

 

Oral liquid 250 mL, 30 (PKU Glytactin RTD 15)

Oral

 

Oral liquid 250 mL, 30 (Tylactin RTD)

Oral

 

Sachets containing oral powder 16 g, 60 (PKU Build 10)

Oral

 

Sachets containing oral powder 20 g, 60 (PKU Restore)

Oral

 

Sachets containing oral powder 32 g, 30 (PKU Build 20)

Oral

 

Sachets containing oral powder 49 g, 30 (Camino Pro Bettermilk)

Oral

 

Sachets containing oral powder 51 g, 30 (PKU Bettermilk Lite)

Oral

Glycomacropeptide formula with long chain polyunsaturated fatty acids and docosahexaenoic acid and low in phenylalanine

Oral liquid 250 mL, 18 (PKU GMPro LQ)

Oral

 

Sachets containing oral powder 27 g, 30 (PKU Sphere15)

Oral

 

Sachets containing oral powder 35 g, 30 (PKU Sphere20)

Oral

Glycopyrronium

Capsule containing powder for oral inhalation 50 micrograms (as bromide) (for use in Breezhaler)

Inhalation by mouth

Golimumab

Injection 100 mg in 1 mL single use pre‑filled pen

Injection

 

Injection 50 mg in 0.5 mL single use pre‑filled pen

Injection

 

Injection 50 mg in 0.5 mL single use pre‑filled syringe

Injection

Goserelin

Subcutaneous implant (long acting) 10.8 mg (as acetate) in pre‑filled injection syringe

Implantation

 

Subcutaneous implant 3.6 mg (as acetate) in pre‑filled injection syringe

Implantation

Goserelin and bicalutamide

Pack containing 1 subcutaneous implant containing goserelin 10.8 mg (as acetate) in pre‑filled injection syringe and 28 tablets bicalutamide 50 mg

Implantation/oral

 

Pack containing 1 subcutaneous implant containing goserelin 10.8 mg (as acetate) in pre‑filled injection syringe and 84 tablets bicalutamide 50 mg

Implantation/oral

 

Pack containing 1 subcutaneous implant containing goserelin 3.6 mg (as acetate) in pre‑filled injection syringe and 28 tablets bicalutamide 50 mg

Implantation/oral

Granisetron

Concentrated injection 3 mg (as hydrochloride) in 3 mL

Injection

 

Tablet 2 mg (as hydrochloride)

Oral

Grazoprevir with elbasvir

Tablet containing grazoprevir 100 mg with elbasvir 50 mg

Oral

Griseofulvin

Tablet 125 mg

Oral

 

Tablet 500 mg

Oral

Guanfacine

Tablet 1 mg (as hydrochloride)

Oral

 

Tablet 2 mg (as hydrochloride)

Oral

 

Tablet 3 mg (as hydrochloride)

Oral

 

Tablet 4 mg (as hydrochloride)

Oral

Guselkumab

Injection 100 mg in 1 mL single use pre‑filled syringe

Injection

Haloperidol

Injection 5 mg in 1 mL

Injection

 

Oral solution 2 mg per mL, 100 mL

Oral

 

Tablet 1.5 mg

Oral

 

Tablet 5 mg

Oral

 

Tablet 500 micrograms

Oral

Haloperidol decanoate

I.M. injection equivalent to 150 mg haloperidol in 3 mL ampoule

Injection

 

I.M. injection equivalent to 50 mg haloperidol in 1 mL ampoule

Injection

Heparin

Injection (preservative‑free) 5,000 I.U. (as sodium) in 5 mL

Injection

 

Injection 5,000 units (as sodium) in 0.2 mL

Injection

High fat formula with vitamins, minerals and trace elements and low in protein and carbohydrate

Oral liquid 200 mL, 32 (KetoCal 4:1 LQ)

Oral

 

Oral powder 300 g (KetoCal 3:1)

Oral

 

Oral powder 300 g (KetoCal 4:1)

Oral

 

Oral semi‑solid 100 g, 48 (Keyo)

Oral

Hyaluronic acid

Eye drops containing sodium hyaluronate 1 mg per mL, 10 mL

Application to the eye

 

Eye drops containing sodium hyaluronate 2 mg per mL, 10 mL

Application to the eye

Hydralazine

Tablet containing hydralazine hydrochloride 25 mg

Oral

 

Tablet containing hydralazine hydrochloride 50 mg

Oral

Hydrochlorothiazide

Tablet 25 mg

Oral

Hydrochlorothiazide with amiloride

Tablet containing hydrochlorothiazide 50 mg with amiloride hydrochloride 5 mg

Oral

Hydrocortisone

Cream containing hydrocortisone acetate 10 mg per g, 50 g

Application

 

Eye ointment containing hydrocortisone acetate 10 mg per g, 5 g

Application to the eye

 

Injection 100 mg (as sodium succinate) with 2 mL solvent

Injection

 

Injection 250 mg (as sodium succinate) with 2 mL solvent

Injection

 

Ointment containing hydrocortisone acetate 10 mg per g, 50 g

Application

 

Rectal foam containing hydrocortisone acetate 90 mg per applicatorful, 14 applications, aerosol 21.1 g

Rectal

 

Tablet 20 mg

Oral

 

Tablet 4 mg

Oral

Hydromorphone

Injection containing hydromorphone hydrochloride 10 mg in 1 mL

Injection

 

Injection containing hydromorphone hydrochloride 2 mg in 1 mL

Injection

 

Oral liquid containing hydromorphone hydrochloride 1 mg per mL, 200 mL

Oral

 

Tablet (modified release) containing hydromorphone hydrochloride 16 mg

Oral

 

Tablet (modified release) containing hydromorphone hydrochloride 32 mg

Oral

 

Tablet (modified release) containing hydromorphone hydrochloride 4 mg

Oral

 

Tablet (modified release) containing hydromorphone hydrochloride 64 mg

Oral

 

Tablet (modified release) containing hydromorphone hydrochloride 8 mg

Oral

 

Tablet containing hydromorphone hydrochloride 2 mg

Oral

 

Tablet containing hydromorphone hydrochloride 4 mg

Oral

 

Tablet containing hydromorphone hydrochloride 8 mg

Oral

Hydroxocobalamin

Injection 1 mg (as acetate) in 1 mL

Injection

 

Injection 1 mg (as chloride) in 1 mL

Injection

Hydroxycarbamide

Capsule 500 mg

Oral

Hydroxychloroquine

Tablet containing hydroxychloroquine sulfate 200 mg

Oral

Hydroxyethyl starch 130/0.4

I.V. infusion 30 g per 500 mL, 500 mL

Injection

Hyoscine

Injection containing hyoscine butylbromide 20 mg in 1 mL

Injection

Hypromellose

0.3% w/v eye drops, 10 mL (preservative free)

Application to the eye

 

Eye drops 3 mg per mL, 10 mL

Application to the eye

 

Eye drops 5 mg per mL, 15 mL

Application to the eye

Hypromellose with carbomer 980

Ocular lubricating gel 3 mg‑2 mg per g, 10 g

Application to the eye

Hypromellose with dextran

Eye drops containing 3 mg hypromellose 2900 with 1 mg dextran 70 per mL, single dose units 0.4 mL, 28

Application to the eye

 

Eye drops containing 3 mg hypromellose 4500 with 1 mg dextran 70 per mL, 15 mL

Application to the eye

Ibandronic acid

Tablet 50 mg (as ibandronate sodium monohydrate)

Oral

Ibrutinib

Capsule 140 mg

Oral

Ibuprofen

Tablet 400 mg

Oral

Icatibant

Injection 30 mg (as acetate) in 3 mL single use pre‑filled syringe

Injection

Idelalisib

Tablet 100 mg

Oral

 

Tablet 150 mg

Oral

Imatinib

Capsule 100 mg (as mesilate)

Oral

 

Capsule 400 mg (as mesilate)

Oral

 

Tablet 100 mg (as mesilate)

Oral

 

Tablet 400 mg (as mesilate)

Oral

Imipramine

Tablet containing imipramine hydrochloride 10 mg

Oral

 

Tablet containing imipramine hydrochloride 25 mg

Oral

 

Tablet containing imipramine hydrochloride 25 mg USP

Oral

Imiquimod

Cream 50 mg per g, 2 g, 2

Application

 

Cream 50 mg per g, 250 mg single use sachets, 12

Application

Indacaterol

Capsule containing powder for oral inhalation 150 micrograms (as maleate) (for use in Breezhaler)

Inhalation by mouth

 

Capsule containing powder for oral inhalation 300 micrograms (as maleate) (for use in Breezhaler)

Inhalation by mouth

Indacaterol with glycopyrronium

Capsule containing powder for oral inhalation indacaterol 110 micrograms (as maleate) with glycopyrronium 50 micrograms (as bromide) (for use in Breezhaler)

Inhalation by mouth

Indapamide

Tablet containing indapamide hemihydrate 1.5 mg (sustained release)

Oral

 

Tablet containing indapamide hemihydrate 2.5 mg

Oral

Indometacin

Capsule 25 mg

Oral

 

Suppository 100 mg

Rectal

Insect allergen extract‑honey bee venom

Injection set containing 550 micrograms

Injection

 

Injection set containing 550 micrograms with diluent

Injection

Insect allergen extract‑paper wasp venom

Injection set containing 550 micrograms

Injection

 

Injection set containing 550 micrograms with diluent

Injection

Insect allergen extract‑yellow jacket venom

Injection set containing 550 micrograms

Injection

 

Injection set containing 550 micrograms with diluent

Injection

Insulin aspart

Injection (human analogue) (fast acting) 100 units per mL, 10 mL vial

Injection

 

Injection (human analogue) 100 units per mL, 10 mL vial

Injection

 

Injections (human analogue) (fast acting), pre‑filled pen, 100 units per mL, 3 mL, 5

Injection

 

Injections (human analogue), cartridges, 100 units per mL, 3 mL, 5

Injection

Insulin aspart with insulin aspart protamine suspension

Injections (human analogue), cartridges, 30 units‑70 units per mL, 3 mL, 5

Injection

Insulin degludec with insulin aspart

Injections, cartridges, 70 units‑30 units per mL, 3 mL, 5

Injection

 

Injections, pre‑filled pen, 70 units‑30 units per mL, 3 mL, 5

Injection

Insulin detemir

Injections (human analogue), cartridges, 100 units per mL, 3 mL, 5

Injection

Insulin glargine

Injections (human analogue), cartridge, 300 units per mL, 1.5 mL, 3

Injection

 

Injections (human analogue), cartridges, 100 units per mL, 3 mL, 5

Injection

 

Injections (human analogue), cartridges, 300 units per mL, 1.5 mL, 5

Injection

Insulin glulisine

Injection (human analogue) 100 units per mL, 10 mL

Injection

 

Injections (human analogue), cartridges, 100 units per mL, 3 mL, 5

Injection

Insulin isophane

Injection (human) 100 units per mL, 10 mL

Injection

 

Injections (human), cartridges, 100 units per mL, 3 mL, 5

Injection

Insulin lispro

Injection (human analogue) 100 units per mL, 10 mL vial

Injection

 

Injections (human analogue), cartridges, 100 units per mL, 3 mL, 5

Injection

 

Injections (human analogue), pre‑filled pen, 200 units per mL, 3 mL, 5

Injection

Insulin lispro with insulin lispro protamine suspension

Injections (human analogue), cartridges, 25 units‑75 units per mL, 3 mL, 5

Injection

 

Injections (human analogue), cartridges, 50 units‑50 units per mL, 3 mL, 5

Injection

Insulin neutral

Injection (human) 100 units per mL, 10 mL

Injection

 

Injections (human), cartridges, 100 units per mL, 3 mL, 5

Injection

Insulin neutral with insulin isophane

Injection (human) 30 units‑70 units per mL, 10 mL

Injection

 

Injections (human), cartridges, 30 units‑70 units per mL, 3 mL, 5

Injection

 

Injections (human), cartridges, 50 units‑50 units per mL, 3 mL, 5

Injection

Interferon alfa‑2a

Injection 3,000,000 I.U. in 0.5 mL single dose pre‑filled syringe

Injection

 

Injection 9,000,000 I.U. in 0.5 mL single dose pre‑filled syringe

Injection

Interferon beta‑1a

Injection 30 micrograms (6,000,000 I.U.) in 0.5 mL single dose pre‑filled syringe

Injection

 

Injection 44 micrograms (12,000,000 I.U.) in 0.5 mL single dose autoinjector

Injection

 

Injection 44 micrograms (12,000,000 I.U.) in 0.5 mL single dose pre‑filled syringe

Injection

 

Solution for injection 132 micrograms in 1.5 mL multidose cartridge

Injection

Interferon beta‑1b

Injection set including 1 vial powder for injection 8,000,000 I.U. (250 micrograms) and solvent

Injection

Ipratropium

Nebuliser solution containing ipratropium bromide 250 micrograms (as monohydrate) in 1 mL single dose units, 30

Inhalation

 

Nebuliser solution containing ipratropium bromide 500 micrograms (as monohydrate) in 1 mL single dose units, 30

Inhalation

 

Pressurised inhalation containing ipratropium bromide monohydrate 21 micrograms per dose, 200 doses (CFC‑free formulation)

Inhalation by mouth

Irbesartan

Tablet 150 mg

Oral

 

Tablet 300 mg

Oral

 

Tablet 75 mg

Oral

Irbesartan with hydrochlorothiazide

Tablet 150 mg‑12.5 mg

Oral

 

Tablet 300 mg‑12.5 mg

Oral

 

Tablet 300 mg‑25 mg

Oral

Iron polymaltose complex

Injection 100 mg (iron) in 2 mL

Injection

Iron sucrose

Concentrate for solution for infusion 2.7 g (equivalent to 100 mg iron (III)) in 5 mL

Injection

Isoleucine with carbohydrate

Sachets of oral powder 4 g containing 1 g isoleucine, 30 (Isoleucine 1000)

Oral

 

Sachets of oral powder 4 g containing 50 mg isoleucine, 30 (Isoleucine 50)

Oral

Isoniazid

Tablet 100 mg

Oral

Isosorbide dinitrate

Tablet 5 mg (sublingual)

Oral

Isosorbide mononitrate

Tablet 120 mg (sustained release)

Oral

 

Tablet 60 mg (sustained release)

Oral

Isotretinoin

Capsule 10 mg

Oral

 

Capsule 20 mg

Oral

 

Capsule 30 mg

Oral

 

Capsule 40 mg

Oral

 

Capsule 5 mg

Oral

Itraconazole

Capsule 100 mg

Oral

 

Capsule 50 mg

Oral

Ivabradine

Tablet 5 mg (as hydrochloride)

Oral

 

Tablet 7.5 mg (as hydrochloride)

Oral

Ivermectin

Tablet 3 mg

Oral

Ixekizumab

Injection 80 mg in 1 mL single dose pre‑filled pen

Injection

Ketoconazole

Cream 20 mg per g, 30 g

Application

 

Shampoo 20 mg per g, 60 mL

Application

Ketoprofen

Capsule 200 mg (sustained release)

Oral

Labetalol

Tablet containing labetalol hydrochloride 100 mg

Oral

 

Tablet containing labetalol hydrochloride 200 mg

Oral

Lacosamide

Oral solution 10 mg per mL, 200 mL

Oral

 

Tablet 100 mg

Oral

 

Tablet 150 mg

Oral

 

Tablet 200 mg

Oral

 

Tablet 50 mg

Oral

Lamotrigine

Tablet 100 mg

Oral

 

Tablet 200 mg

Oral

 

Tablet 25 mg

Oral

 

Tablet 5 mg

Oral

 

Tablet 50 mg

Oral

Lansoprazole

Capsule 15 mg

Oral

 

Capsule 30 mg

Oral

 

Tablet 15 mg (orally disintegrating)

Oral

 

Tablet 30 mg (orally disintegrating)

Oral

Lanthanum

Tablet, chewable, 1000 mg (as carbonate hydrate)

Oral

 

Tablet, chewable, 500 mg (as carbonate hydrate)

Oral

 

Tablet, chewable, 750 mg (as carbonate hydrate)

Oral

Lapatinib

Tablet 250 mg (as ditosilate monohydrate)

Oral

Latanoprost

Eye drops 50 micrograms per mL, 2.5 mL

Application to the eye

Latanoprost with timolol

Eye drops 50 micrograms latanoprost with timolol 5 mg (as maleate) per mL, 2.5 mL

Application to the eye

Ledipasvir with sofosbuvir

Tablet containing 90 mg ledipasvir with 400 mg sofosbuvir

Oral

Leflunomide

Tablet 10 mg

Oral

 

Tablet 20 mg

Oral

Lenvatinib

Capsule 10 mg (as mesilate)

Oral

 

Capsule 4 mg (as mesilate)

Oral

Lercanidipine

Tablet containing lercanidipine hydrochloride 10 mg

Oral

 

Tablet containing lercanidipine hydrochloride 20 mg

Oral

Lercanidipine with enalapril

Tablet containing lercanidipine hydrochloride 10 mg with enalapril maleate 10 mg

Oral

 

Tablet containing lercanidipine hydrochloride 10 mg with enalapril maleate 20 mg

Oral

Letrozole

Tablet 2.5 mg

Oral

Leuprorelin

I.M. injection (3 month modified release), powder for injection containing leuprorelin acetate 30 mg with diluent in pre‑filled dual‑chamber syringe

Injection

 

I.M. injection (modified release), powder for injection containing leuprorelin acetate 22.5 mg with diluent in pre‑filled dual‑chamber syringe

Injection

 

I.M. injection (modified release), powder for injection containing leuprorelin acetate 30 mg with diluent in pre‑filled dual‑chamber syringe

Injection

 

I.M. injection (modified release), powder for injection containing leuprorelin acetate 45 mg with diluent in pre‑filled dual‑chamber syringe

Injection

 

I.M. injection (modified release), powder for injection containing leuprorelin acetate 7.5 mg with diluent in pre‑filled dual‑chamber syringe

Injection

 

Suspension for subcutaneous injection (modified release) containing leuprorelin acetate 22.5 mg, injection set

Injection

 

Suspension for subcutaneous injection (modified release) containing leuprorelin acetate 30 mg, injection set

Injection

 

Suspension for subcutaneous injection (modified release) containing leuprorelin acetate 45 mg, injection set

Injection

 

Suspension for subcutaneous injection (modified release) containing leuprorelin acetate 7.5 mg, injection set

Injection

Leuprorelin and bicalutamide

Pack containing 1 syringe containing leuprorelin 22.5 mg (as acetate) and 28 tablets bicalutamide 50 mg

Injection/oral

 

Pack containing 1 syringe containing leuprorelin 22.5 mg (as acetate) and 84 tablets bicalutamide 50 mg

Injection/oral

 

Pack containing 1 syringe containing leuprorelin 7.5 mg (as acetate) and 28 tablets bicalutamide 50 mg

Injection/oral

Levetiracetam

Oral solution 100 mg per mL, 300 mL

Oral

 

Tablet 1 g

Oral

 

Tablet 250 mg

Oral

 

Tablet 500 mg

Oral

Levodopa with benserazide

Capsule containing levodopa 100 mg with 25 mg benserazide (as hydrochloride)

Oral

 

Capsule containing levodopa 100 mg with 25 mg benserazide (as hydrochloride) (sustained release)

Oral

 

Capsule containing levodopa 200 mg with 50 mg benserazide (as hydrochloride)

Oral

 

Capsule containing levodopa 50 mg with 12.5 mg benserazide (as hydrochloride)

Oral

 

Dispersible tablet containing levodopa 100 mg with 25 mg benserazide (as hydrochloride)

Oral

 

Dispersible tablet containing levodopa 50 mg with 12.5 mg benserazide (as hydrochloride)

Oral

 

Tablet containing levodopa 100 mg with 25 mg benserazide (as hydrochloride)

Oral

 

Tablet containing levodopa 200 mg with 50 mg benserazide (as hydrochloride)

Oral

Levodopa with carbidopa

Intestinal gel containing levodopa 20 mg with carbidopa monohydrate 5 mg per mL, 100 mL

Intra‑intestinal

 

Tablet (modified release) 200 mg‑50 mg (as monohydrate)

Oral

 

Tablet (prolonged release) 200 mg‑50 mg

Oral

 

Tablet 100 mg‑25 mg (as monohydrate)

Oral

 

Tablet 250 mg‑25 mg (as monohydrate)

Oral

Levodopa with carbidopa and entacapone

Tablet 100 mg‑25 mg (as monohydrate)‑200 mg

Oral

 

Tablet 125 mg‑31.25 mg (as monohydrate)‑200 mg

Oral

 

Tablet 150 mg‑37.5 mg (as monohydrate)‑200 mg

Oral

 

Tablet 200 mg‑50 mg (as monohydrate)‑200 mg

Oral

 

Tablet 50 mg‑12.5 mg (as monohydrate)‑200 mg

Oral

 

Tablet 75 mg‑18.75 mg (as monohydrate)‑200 mg

Oral

Levonorgestrel

Intrauterine drug delivery system 19.5 mg

Intrauterine

 

Intrauterine drug delivery system 52 mg

intrauterine

 

Tablets 30 micrograms, 28

Oral

Levonorgestrel with ethinylestradiol

Pack containing 21 tablets 100 micrograms‑20 micrograms and 7 inert tablets

Oral

 

Pack containing 21 tablets 125 micrograms‑50 micrograms and 7 inert tablets

Oral

 

Pack containing 21 tablets 150 micrograms‑30 micrograms and 7 inert tablets

Oral

 

Pack containing 6 tablets 50 micrograms‑30 micrograms, 5 tablets 75 micrograms‑40 micrograms, 10 tablets 125 micrograms‑30 micrograms and 7 inert tablets

Oral

Levothyroxine

Tablet containing 100 micrograms anhydrous levothyroxine sodium

Oral

 

Tablet containing 200 micrograms anhydrous levothyroxine sodium

Oral

 

Tablet containing 50 micrograms anhydrous levothyroxine sodium

Oral

 

Tablet containing 75 micrograms anhydrous levothyroxine sodium

Oral

Lidocaine

Infusion containing lidocaine hydrochloride 500 mg in 5 mL

Injection

Linagliptin

Tablet 5 mg

Oral

Linagliptin with metformin

Tablet containing 2.5 mg linagliptin with 1000 mg metformin hydrochloride

Oral

 

Tablet containing 2.5 mg linagliptin with 500 mg metformin hydrochloride

Oral

 

Tablet containing 2.5 mg linagliptin with 850 mg metformin hydrochloride

Oral

Lincomycin

Injection 600 mg (as hydrochloride monohydrate) in 2 mL

Injection

Liothyronine

Tablet containing liothyronine sodium 20 micrograms

Oral

Lisdexamfetamine

Capsule containing lisdexamfetamine dimesilate 20 mg

Oral

 

Capsule containing lisdexamfetamine dimesilate 30 mg

Oral

 

Capsule containing lisdexamfetamine dimesilate 40 mg

Oral

 

Capsule containing lisdexamfetamine dimesilate 50 mg

Oral

 

Capsule containing lisdexamfetamine dimesilate 60 mg

Oral

 

Capsule containing lisdexamfetamine dimesilate 70 mg

Oral

Lisinopril

Tablet 10 mg

Oral

 

Tablet 20 mg

Oral

 

Tablet 5 mg

Oral

Lithium

Tablet containing lithium carbonate 250 mg

Oral

 

Tablet containing lithium carbonate 450 mg (slow release)

Oral

Loperamide

Capsule containing loperamide hydrochloride 2 mg

Oral

Lorlatinib

Tablet 25 mg

Oral

 

Tablet 100 mg

Oral

Losartan

Tablet containing losartan potassium 25 mg

Oral

 

Tablet containing losartan potassium 50 mg

Oral

Lurasidone

Tablet containing lurasidone hydrochloride 40 mg

Oral

 

Tablet containing lurasidone hydrochloride 80 mg

Oral

Macrogol 3350

Oral liquid 13.125 g in 25 mL with electrolytes, 500 mL

Oral

 

Powder for oral solution 510 g

Oral

 

Sachets containing powder for oral solution 13.125 g with electrolytes, 30

Oral

Magnesium

Tablet 37.4 mg (as aspartate dihydrate)

Oral

Medroxyprogesterone

Injection containing medroxyprogesterone acetate 150 mg in 1 mL

Injection

 

Tablet containing medroxyprogesterone acetate 10 mg

Oral

 

Tablet containing medroxyprogesterone acetate 100 mg

Oral

 

Tablet containing medroxyprogesterone acetate 200 mg

Oral

 

Tablet containing medroxyprogesterone acetate 250 mg

Oral

 

Tablet containing medroxyprogesterone acetate 5 mg

Oral

 

Tablet containing medroxyprogesterone acetate 500 mg

Oral

Mefenamic acid

Capsule 250 mg

Oral

Meloxicam

Capsule 15 mg

Oral

 

Capsule 7.5 mg

Oral

 

Tablet 15 mg

Oral

 

Tablet 7.5 mg

Oral

Melphalan

Tablet 2 mg

Oral

Memantine

Tablet containing memantine hydrochloride 10 mg

Oral

 

Tablet containing memantine hydrochloride 20 mg

Oral

Mercaptopurine

Oral suspension containing mercaptopurine monohydrate 20 mg per mL, 100 mL

Oral

 

Tablet containing mercaptopurine monohydrate 50 mg

Oral

Mesalazine

Enemas 1 g in 100 mL, 7

Rectal

 

Enemas 2 g in 60 mL, 7

Rectal

 

Enemas 4 g in 60 mL, 7

Rectal

 

Rectal foam 1 g per applicatorful, 14 applications, aerosol 80 g

Rectal

 

Sachet containing granules, 1 g per sachet

Oral

 

Sachet containing granules, 1.5 g per sachet

Oral

 

Sachet containing granules, 3 g per sachet

Oral

 

Sachet containing granules, 500 mg per sachet

Oral

 

Sachet containing prolonged release granules, 1 g per sachet

Oral

 

Sachet containing prolonged release granules, 2 g per sachet

Oral

 

Sachet containing prolonged release granules, 4 g per sachet

Oral

 

Suppository (moulded) 1 g

Rectal

 

Suppository 1 g

Rectal

 

Tablet 1 g (enteric coated)

Oral

 

Tablet 1 g (prolonged release)

Oral

 

Tablet 1.2 g (prolonged release)

Oral

 

Tablet 250 mg (enteric coated)

Oral

 

Tablet 500 mg (enteric coated)

Oral

 

Tablet 500 mg (prolonged release)

Oral

 

Tablet 800 mg (enteric coated)

Oral

Mesna

Solution for I.V. injection 1 g in 10 mL ampoule

Injection

 

Solution for I.V. injection 400 mg in 4 mL ampoule

Injection

Metformin

Tablet containing metformin hydrochloride 500 mg

Oral

 

Tablet containing metformin hydrochloride 850 mg

Oral

 

Tablet containing metformin hydrochloride 1 g

Oral

 

Tablet (extended release) containing metformin hydrochloride 500 mg

Oral

 

Tablet (extended release) containing metformin hydrochloride 1 g

Oral

 

Tablet (prolonged release) containing metformin hydrochloride 500 mg